Next Article in Journal
An Assessment of Serum Selenium Concentration in Women with Endometrial Cancer
Previous Article in Journal
The Serial Mediation of the Association between Breakfast Skipping and Suicidality by Weight Status and Depressive Symptoms: Findings from the National Youth Risk Behavior Surveys of the United States
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Chicory: Understanding the Effects and Effectors of This Functional Food

1
UMR Transfrontalière BioEcoAgro N° 1158, Univ. Lille, INRAE, Univ. Liège, UPJV, JUNIA, Univ. Artois, Univ. Littoral Côte d’Opale, ICV, SFR Condorcet FR CNRS 3417—Institut Charles Viollette, 59655 Villeneuve d’Ascq, France
2
Joint Laboratory CHIC41H University of Lille-Florimond-Desprez, Cité scientifique, 59655 Villeneuve d’Ascq, France
3
UMR Transfontalière BioEcoAgro N° 1158, Univ. Lille, INRAE, Univ. Liège, UPJV, JUNIA, Univ. Artois, Univ. Littoral Côte d’Opale, ICV, SFR Condorcet FR CNRS 3417—BIOlogie des Plantes et Innovation (BIOPI), 80025 Amiens, France
4
Plateforme Analytique UFR des Sciences, UPJV, Bâtiment Serres-Transfert Rue Dallery-Passage du Sourire d’Avril, 80039 Amiens, France
5
Department of Food Sciences–Microbiology, FARAH, University of Liege, 4000 Liege, Belgium
*
Author to whom correspondence should be addressed.
Nutrients 2022, 14(5), 957; https://doi.org/10.3390/nu14050957
Submission received: 2 February 2022 / Accepted: 22 February 2022 / Published: 23 February 2022
(This article belongs to the Topic Applied Sciences in Functional Foods)

Abstract

:
Industrial chicory has been the subject of numerous studies, most of which provide clinical observations on its health effects. Whether it is the roasted root, the flour obtained from the roots or the different classes of molecules that enter into the composition of this plant, understanding the molecular mechanisms of action on the human organism remains incomplete. In this study, we were interested in three molecules or classes of molecules present in chicory root: fructose, chlorogenic acids, and sesquiterpene lactones. We conducted experiments on the murine model and performed a nutrigenomic analysis, a metabolic hormone assay and a gut microbiota analysis, associated with in vitro observations for different responses. We have highlighted a large number of effects of all these classes of molecules that suggest a pro-apoptotic activity, an anti-inflammatory, antimicrobial, antioxidant, hypolipidemic and hypoglycemic effect and also an important role in appetite regulation. A significant prebiotic activity was also identified. Fructose seems to be the most involved in these activities, contributing to approximately 83% of recorded responses, but the other classes of tested molecules have shown a specific role for these different effects, with an estimated contribution of 23–24%.

Graphical Abstract

1. Introduction

Industrial chicory (Cichorium intybus var. sativum) has been analyzed for its various dietary and medicinal effects. A substantial amount of clinical evidence depicts chicory to be anti-diabetic, immunomodulatory, anti-tumor, antioxidant, anthelmintic, and prebiotic. In addition, chicory has been shown to promote good digestion, to regulate appetite, and to decrease the risk of gastrointestinal diseases [1].
The chicory root, processed into flour and used as an ingredient for pastries, has been proposed as a functional food; potential mechanisms by which the chicory acts on cancer prevention, antibacterial and antiviral defense, hypoglycemic, hypolipidemic and antioxidant effects have been identified [2]. Among the major compounds of chicory root, inulin has been the subject of multiple studies concerning its prebiotic effect [2,3], but less is known about the specific mechanisms of other molecules that enter the composition of roots. The hydrolysis products of inulin, fructose and oligofructose, have been described to have multiple beneficial effects on bowel functions [4]. Chlorogenic acids (CGA) have been described to improve the insulin sensitivity in diabetic rats [5] and were also associated with major in vivo antioxidant properties [6] and an in vitro antibacterial activity [7]. Sesquiterpene lactones (STL), from the chicory leaves and roots, are known for their strong inhibitory effect on some nematodes infecting livestock [8,9,10], and more generally, STL are known for their antitumor, antimicrobial, antioxidant, hepatoprotective, antiprotozoal, and antiaging properties [11]. Both CGA and STL were also studied for their anti-inflammatory effect in vitro as well as in vivo [6,12]. Some other molecules present in chicory roots and leaves, such as flavonoids or tannins, were studied for their specific health effects and their contents correlated with antioxidant [13] and anti-nematode [14] properties.
In this work, we looked at three classes of molecules that are part of the composition of the chicory flour: fructose, CGA and STL. We experimented on the murine model and performed a nutrigenomic analysis, a metabolic hormone assay and a metagenomic analysis of the gut microbiota, to target the major health effects and molecular mechanisms of action in these compounds. Results were supported by in vitro apoptosis detection on human hepatocellular carcinoma HepG2 cells, using flow cytometry, by in vitro inflammatory cytokines secretion assay on promonocytic human cell line U937, differentiated into macrophages, and by a cell-free system antioxidant assay.

2. Materials and Methods

  • Chicory product obtaining and chemical analysis of their composition
Roots from industrial chicory (Cichorium intybus var. sativum) provided by Florimond-Desprez Veuve et Fils SAS (Cappelle-en-Pévèle, France) were processed by Leroux SAS (Orchies, France) and the corresponding flour was delivered by Waast Mill (Mons-en-Pévèle, France). This flour is a trade product that comes from a mixture of several genotypes with a significantly different chemical composition. An aqueous decoction of this flour was produced to feed the mice as described by Pouille et al. [2]. A mixture of water/methanol (1:1) was added to either 100 mg of a randomized sample of chicory flour or 100 mg of dry residue obtained after lyophilisation of chicory decoction. The samples were mixed for 10 min at 80 °C, using a ThermoMixer® (Eppendorf AG, Hamburg, Germany) at 2000 rpm, followed by 10 min of sonication at 80 °C using an ultrasonic bath at 35 kHz. The samples were centrifuged at 4 °C for 10 min at 12,000 rpm. The supernatant was diluted 20 times with methanol/water (50/50). All samples were filtered through 0.22 μm PTFE membrane filters before analysis by ultra-performance liquid chromatography coupled to high-resolution mass spectrometry (UPLC-HRMS) and nuclear magnetic resonance (NMR). UPLC-HRMS analysis was performed on an ACQUITY UPLC I-class chain coupled with the Vion IMS Q-TOF high resolution mass spectrometer, equipped with an electrospray (ESI) (Waters, Manchester, UK) ionization source (Z-spray) and an additional spray for the reference compound (Lock Spray). A double detection in the positive and negative mode was performed by ESI mass spectrometry (range 50–2000 Da) and by a PDA diode array detector (UV detection between 190–500 nm). Separation was performed using a KINETEX Biphenyl (100 × 2.1 mm, 1.7 μm) column (Phenomenex) heated at 55 °C with a mobile phase (solvent A (0.1% formic acid in water) and solvent B (0.1% formic acid in methanol)) flow (0.55 mL·min−1) and the same gradient elution as our previous study [15]. The spectra obtained were acquired and processed with UNIFI software (version 1.9.4, Waters) and enabled us to generate the data matrix for untargeted metabolomics analyses with classical parameters. Calibration mixture solution of target metabolites at concentrations of 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5 and 5 μM were prepared by dilution in three replicates. Area values of the extracted ion chromatograms were transferred to Excel (Microsoft Excel 2011 v. 14.7.2, Microsoft, Redmond, WA, USA).
The NMR untargeted metabolomics protocol was adapted from our previous study [16]. Briefly, the supernatant (500 μL) was dried under vacuum and then dissolved in 800 μL of deuterated solvent prepared in a mixture of (1:1) Methanol-d4: KH2PO4 buffer (0.1 M) in D2O at pH 6.0 with TMSP (0.0125%), NaN3 (0.6 mg·mL−1), and maleic acid (1 mM). Then, the samples were briefly vortexed, sonicated, and centrifuged. The supernatant was placed in 5-mm NMR tubes and then used for NMR analysis. All NMR spectra were acquired at 300 K with a Bruker Avance III 600 MHz spectrometer operating at 600.13 MHz for 1H, and 150.91 MHz for 13C, using a 5-mm double resonance broadband probe, equipped with z-gradient (BBFO 5 mm tube). For quantitative analysis, classical 1D 1H-NMR spectra were collected using 128 scans of 131 K data points and a spectral width of 8417 Hz with a relaxation delay of 25 s. For metabolomics profiling, a NOESY-1D water suppression pulse sequence was used and generated spectra were collected using 256 scans of 131 K data points and a spectral width of 8417 Hz with a relaxation delay of 25 s. NMRProcFlow web application [17] was used to generate the untargeted metabolomics data matrix and the quantitative 1H-NMR data. Bins with the lowest overlapping signals were kept (0.9 to 3.25 ppm and 4.5 to 8.5 ppm). Signals of maleic acid were used to calculate the absolute concentration of targeted metabolites. A combined data matrix with NMR (161 bins) and UPLC-HRMS (positive (77 ions) and negative (71 ions) data) untargeted analyses were generated. The percentage of the relative standard deviation (% RSD) was calculated for all metabolic features in each condition and the features with % RSD greater than 25% were removed due to variability. Metabolite pick areas were expressed in percentage (100% corresponds to the mean for chicory flour). Heatmap data was clustered (Ward’s method was used to form hierarchical clustering) and visualized (using the pheatmap-package, version 1.0.12).
  • Animal experiments and ethical statements
Male BALB/cOlaHsd 8-week-old mice were used for experiments in agreement with Directive 2010/63/EEC for the protection of animals used for scientists and in accordance with Law 2012-10 (2012) and 2013-118 (2013). The protocol was approved by the Ethics Committee in charge of animal experiments. The mice were randomly divided into six groups (n = 5/group) and housed in a controlled environment (with a temperature of 22 °C, a 12 h/12 h light/dark cycle and ad libitum access to standardized food and water). Mice were fed with an aqueous decoction of root flour (Chic) and with three other molecules or classes of molecules: fructose (Fru), CGA and STL water solution as indicated in Table 1. The mice gavages consisted in a daily force-feeding of 500 µL of Chic, Fru, CGA or STL besides the standard chow (Diet A04C-10, Scientific Animal Food and Engineering, Augy, France). For the chicory flour, the decoction corresponded to 30 mg root powder/mouse/day that was considered close to human equivalent weight/body mass for a moderated alimentary dose [18]. The administered dose of Fru, CGA and STL was calculated to correspond to the concentration of these compounds in the aqueous extract of chicory flour for daily consumption. This estimation was performed taking into account the variability of these compounds in 5 different chicory genotypes [19] as indicated in Table 1. Controls underwent an equivalent force-feeding with water (Ctr1), the solvent used for chicory decoction and fructose solution, and with 0.83% DMSO (Ctr2) as CGA and STL solutions were prepared with this diluent [20,21]. Six groups of mice were used (Ctr1, Ctr2, Chic, Fru, CGA and STL), nourished for 30 days and individual body weight was regularly registered (File S1). At the end of this period, mice for each condition were sacrificed, the central core of the liver left lobe was cut into cubes, a short segment (1 cm) of the colon was also cut and enterocytes were harvested from upper ileal segments by mucosa scraping method. These tissues were immediately frozen in liquid nitrogen and stored as individual samples at −80 °C for transcriptomics. The feces were individually harvested before the treatment (D0) and after 30 days (D30), and were stored at −80 °C for microbiota analyses. For hormonal assays, 100 µL of blood from the caudal vein was sampled from each animal 30 min after gavage at D30. The blood from each mouse was collected in tubes containing 20 µL 10% EDTA anticoagulant solution and 1 µL dipeptidyl peptidase-4 inhibitor (DPP4-010, Marck, Milipore, Darmstadt, Germany), then centrifuged at 14,000 rpm for 10 min, the plasma containing supernatants collected and stored at −80 °C.

2.1. RNA Extraction and Microarray Analysis

Total RNAs were extracted from hepatic and colon tissues using RNAspin columns (Macherey-Nagel, Düren, Germany). For ileum cells, the NucleoZOL (Macherey-Nagel) kit was used. RNA quality was checked with Nanodrop and absorbance ratios A260/280 and A260/230 were found between 2.0 and 2.2. RNA quality was also examined by RNA ScreenTape Analysis (Agilent) and a minimal RNA integrity number (RIN) of 0.8 was required for all samples.
For the microarray analysis, groups of mice (n = 3) were used for each treatment: (1) a group that received a decoction of chicory flour for 30 days as previously described, (2) a group that received a solution of fructose (Fru) for 30 days, (3) a group that received a solution of CGA for 30 days, (4) a group that received a solution of STL for 30 days, (5) two control groups with standard drinking water (Ctr1 and Ctr2) as mentioned before. Three tissues were analyzed: liver, ileum enterocytes and caecum.
Agilent Whole Mouse Genome Microarray Sure Print GE 4 × 44 v2 with oligonucleotide 45,220 probes was used to study the gene expression profile. RNA amplification, staining, hybridization and washing were conducted according to the manufacturer’s specifications. Slides were scanned at 5 µm/pixel resolution using the GenePix 4000B scanner (Molecular Devices Corporation, Sunnyvale, CA, USA). Images were used for grid alignment and expression data digitization with GenePix Pro 6.0 software. Expression data were normalized by Quantile algorithm. The 3 control samples were filtered for p value < 0.05 and the average was calculated for each gene. A fold change (FC) value was calculated between individual treated samples and the mean of corresponding controls. Differentially expressed genes (DEGs) were selected for a threshold >2.0 or <0.5. Functional annotation of DEGs was based on NCBI GenBank and related genes’ physiological processes were assigned with NCBI, AmiGO 2 Gene Ontology and UniProt. KEGG pathway analysis was also used to identify relevant biological pathways of selected genes. All microarray data have been submitted to the NCBI GEO archive for functional genomics data with the accession number GSE190056.

2.2. In Vivo Hormone Detection

Plasma concentrations of leptin and GIP (glucose-dependent insulinotropic polypeptide) were assessed using antibody-immobilized beads specific to each hormone in a Milliplex® Map Kit (Millipore Corporation, Billerica, MA, USA) according to the manufacturer’s instructions. Kit sensitivity was 19 pg·mL−1 for leptin and 1 pg·mL−1 for GIP. The quantification was carried out using the Luminex® 100/200 (Luminex Corporation, Austin, TX, USA) system and the Luminex xPONENT® for LX100/200 software.

2.3. Microbiota Analysis

Total DNA content from mice feces was extracted according to NucleoSpin DNA Stool Kit (Macherey-Nagel, Düren, Germany). The sequencing was done by the GIGA genoproteomic platform of Liège University (Belgium). For sequencing the amplification of the V1-V3 region of the 16S rDNA and the library preparation were performed with the following primers: direct (5′-GAGAGTTTGATYMTGGCTCAG-3′) and inverse (5′-GAGAGTTTGGCTCAG-3′). Each PCR product was purified with the Agencourt AMPure XP Ball Kit (Beckman Coulter, Pasadena, CA, USA), and subjected to a second round of PCR for indexing, using Nextera XT index 1 and 2 primers. After purification, the PCR products were quantitated using the Quant-IT PicoGreen (Thermo-Fisher Scientific, Waltham, MA, USA) and diluted to 10 ng·μL−1. A final qPCR quantification of each library sample was performed using the KAPA SYBR FAST qPCR Kit (KapaBiosystems, Wilmington, NC, USA) before standardization, pooling, and sequencing on a MiSeq sequencer using v3 reagents (ILLUMINA, San Diego, CA, USA).
Data processing was performed using, respectively, the MOTHUR v1.44 package and the VSearch algorithm [22] for alignment, clustering and chimer detection as previously described by Gérard et al. [23]. After cleaning process, sequences were clustered into operational taxonomic units (OTUs) at 97% of identity. Alignment and taxonomical identification were performed with MOTHUR using SILVA v1.32 database of full-length 16S rDNA gene sequences. A rarefied table of 10,000 reads by sample was used for further analysis. Reads were finally aggregated into phylotypes at the phylum and genus taxonomic level.
All analyses were performed by comparing experimental groups to their respective controls. Normality was controlled with the Shapiro–Wilk test and homogeneity of variances with Bartlett’s test. Statistical paired differences were assessed by ANOVA and Tukey’s test.
PRISM 7 (GraphPad Prism 6.0, Windows Inc., San Diego, CA, USA) was used and differences were considered significant for a p value < 0.05. All the biosample raw reads have been deposited at the National Center for Biotechnology Information (NCBI) and are available under BioProject accession number PRJNA799887. Data obtained from NGS analysis were analyzed for the alpha diversity with Shannon index and graphical representations were performed using GraphPad Prism version 8.00 for windows, GraphPad Software, and beta-diversity with the principal component analysis (PCoA) using the FactoMineR package in R version 3.5.2 (r-project.org).

2.4. In Vitro Cytotoxicity Studies

The cytotoxic effect of samples was analyzed to determine the maximum concentrations that could be used for the other tests. The cytotoxic effect was performed using the cell counting assay-8 (CCK-8) (CK04, Tebu-Bio). The kit was used according to the manufacturer’s instructions. HepG2 and U937 cells were seeded in 96-well culture plates at 8 × 104 cells·cm−2 and 3 × 105 cells·cm−2 respectively. After reaching confluency, the growing medium was replaced by samples diluted at increasing concentrations in Dulbecco’s modified Eagle’s medium (DMEM, 4.5 g·L−1 glucose) or in Roswell Park Memorial Institute medium (RPMI-1640). Culture medium was used as a negative control of cytotoxicity. The cells were incubated at 37 °C for 24 h and the cytotoxic effect of samples was immediately determined.

2.5. In Vitro Apoptosis Assay

The human hepatocellular carcinoma HepG2 cells were grown at 37 °C, 5% CO2 atmosphere, in DMEM supplemented with 10% fetal bovine serum (FBS), 100 U·mL−1 penicillin, 100 μg·mL−1 streptomycin, and 2 mM glutamine. After reaching 80–90% confluency, HepG2 cells were seeded into 24-well culture plates at 8 × 104 cells·cm−2 six days before experiment. The culture medium was discarded and cells were washed with PBS. Apoptosis was induced by adding different amounts of lyophilized chicory decoction or D-fructose powder (0.2%, 0.5%, 1%, 2% and 3%, m/v), and different concentrations of CQA or STL (5, 10, 20, 50, 75 and 100 µM). Resveratrol at a concentration of 200 µM [24] was used as a positive control and DMEM medium as a negative one. The cells were then incubated at 37 °C for 24 h. Early and late apoptotic events were analyzed by flow cytometry (Invitrogen™ Attune™ NxT Flow Cytometer) with the Alexa Fluor 488 annexin V/Dead Cell Apoptosis Kit (Invitrogen, Waltham, MA, USA) according to the manufacturer’s kit manual.

2.6. In Vitro Inflammatory Cytokines Secretion Assay

The promonocytic human cell line U937 was cultured in RPMI 1640 medium supplemented with 10% FBS, 100 U·mL−1 penicillin, 100 μg·mL−1 streptomycin, and 2 mM glutamine in a humidified 5% CO2 atmosphere at 37 °C. For macrophage differentiation, U937 cells were seeded at approximately 3 × 105 cells·cm−2 in 24-well plates with 60 ng·mL−1 phorbol-12-myristate-13-acetate (PMA) for 48 h. Adherent cells were washed with PBS before a 2 h incubation with LPS (10 µg·mL−1; LPS from E. coli O26:B6, Millipore Corporation) and samples. Cell supernatants were collected on ice and centrifuged (1500 rpm 5 min) to eliminate cell debris. The supernatants were aliquoted and stored at −80 °C until further analysis. Secreted Il-1β and TNF-α were quantified using Millipore Human High Sensitivity T Cell kit (EMD Millipore, Darmstadt, Germany) according to the manufacturer’s instructions. The quantification was carried out using the Luminex® 100/200 (Luminex Corporation, Austin, TX, USA) system and the Luminex xPONENT® for LX100/200 software. The cytokine IL-8 was quantified using a human IL-8/CXCL8 Quantikine® ELISA kit (R&D Systems, Inc., Minneapolis, MN, USA). Medium samples were diluted 100-fold according to the kit recommendations.

2.7. Cell-Free Systems Evaluating Antioxidative Sample Effects

All reagents were purchased from Sigma (Saint-Quentin Fallavier, France). The concentration of the starting samples to be diluted was standardized at 10 mg of dry matter per mL. After all assays, the maximal percentage of inhibition obtained for each reactive oxygen species (ROS) at the highest concentration for each sample was also calculated and half-maximal inhibitory concentration (IC50) was determined when practicable.
The superoxide anion inhibition was estimated in a cell-free model adapted from that previously described by Aruoma et al. [25]. Briefly, O2 was produced by the xanthine (0.1 mM)/xanthine oxidase (50 mU·mL−1) system in a Hank’s HEPES buffer (HH) (pH 7.42) and then incubated at 25 °C for 15 min with increasing sample concentrations ranging from 0 to 100 µL·mL−1 of reaction mixture (equivalent to 0 to 1 mg of dry matter per final mL) and with 0.017 mM equine ferricytochrome c (FerC). The appearance of pink coloration corresponds to the FerC reduction (into ferrocytochome C) by the remaining superoxide anions non-inhibited by the samples. An inhibition control cuvette also contained 300 µM cysteine. Spectrophotometry method was used to measure the absorbance at the wavelength of 550 nm. Then, O2 concentrations were calculated thanks the Beer–Lambert law using the ferrocytochrome C extinction coefficient (21.1 × 103 L·mol−1·cm−1). All measurements were performed against a blank cuvette, containing all reagents and samples except xanthine oxidase to avoid any interference. Results were converted into nmol·mL−1 and expressed in bar diagrams ± SD according to the sample volumes involved per mL of reaction mixture. The hydroxyl radical inhibition by the control solutions or sample studied was assayed using a method adapted from that described by Halliwell, Gutteridge and Aruoma [26]. HO. was produced in each tube in 20 mM KH2PO4 buffer at pH 7.4 with 10−11 nmol of hydrogen peroxide per mL. For that, Fenton’s reaction was initiated by adding EDTA-Fe2+ (100 µM FeCl3, 104 µM ethylene diamine tetraacetic acid and 100 µM ascorbic acid). The solutions/sample concentrations (the same as above described for H2O2) were added for HO. to be then inhibited at least partially. Deoxyribose (3 mM) was added to be degraded by the remaining hydroxyl radicals. After boiling for 20 min, malondialdehyde (MDA) was generated as a result of 14 mM thiobarbituric acid and 147 mM trichloroacetic acid. The resulting pink chromogen was measured by spectrophotometry (532 nm). HO. inhibition control tubes were also made with 300 µM cysteine. HO. was expressed in nmol·mL−1, using a standard curve obtained from increasing H2O2 concentrations. The data was presented as bar diagrams ± SD according to the sample volumes involved per mL of reaction mixture. Statistical analysis was conducted using 6 independent assays (GraphPad Prism 7 software for Windows, Inc., San Diego, CA, USA). Provided the population was normal (Shapiro–Wilk’s test at the 5% level) as well as variance homogeneity obtained (non-significative Bartlett’s test at the 5% level), ANOVA was performed (overall Fisher’s test, p < 0.05, followed by the ad-hoc Tukey’s test, p < 0.05). When ANOVA was not applicable, the non-parametric test of Kruskal–Wallis (p < 0.05) followed by Dunn’s test (p < 0.05) were performed.

3. Results

Whole chicory flour (Chic) and three compounds of chicory roots (Fru, CGA and STL) were separately analyzed for their health effects in mice. A whole transcriptomic analysis was conducted using Agilent DNA microarrays to investigate their nutrigenomic effects, the plasmatic hormonal levels were assayed using Luminex technology, and a fecal microbiota metabarcoding analysis was realized by Illumina 16S rDNA sequencing. We carried out parallel in vitro analyses to investigate apoptotic, anti-inflammatory and antioxidant effects of these different compounds.

3.1. Composition of Chicory Products

An untargeted metabolomic approach was conducted using UPLC-HRMS and 1H-NMR data, obtained from the analysis of two types of preparation i.e., chicory flour and its decoction. Similar metabolite profiles were observed when comparing both preparations. However, metabolomic fingerprinting revealed that the extraction of the metabolites during the preparation of the decoction from the chicory flour was slightly less effective. We estimated that during the decoction preparation, several metabolites were extracted in proportion to 70–80% compared to their content in the flour (considered to be 100%) (File S2). A possible explanation may be that in the decoction, the extraction of metabolites in hot water could be incomplete, in particular for hydrophobic compounds; the stirring could also play an important role in the observed results. Metabolites that were used in this work for animal feed were subsequently targeted by quantitative 1H-NMR and also by UPLC-HRMS and results are presented in Table 2. The content of CGA and STL in the decoction seems, generally, similar to that of flour. We found that only lactucin content was higher in the decoction, while the content of fructose was slightly lower in the latter. Despite these minor quantitative differences, the quality composition of the chicory decoction remains identical to that of the chicory flour and, therefore, its use for a mouse diet could be relevant for evaluating the chicory roots effects.

3.2. Nutrigenomic Analyses

Diet-induced gene expression profiles were analyzed in the liver, ileum enterocytes and caecum of mice after 30 days of daily ingestion of aqueous extracts of Chic, Fru, CGA or STL solutions. A total of 57 profiles were found differentially expressed during the chicory diet in these different tissues (Figure 1, File S3). A first group of nine DEGs, modified by the chicory diet, is involved in cell proliferation and apoptosis, and their deregulation suggests a cell growth arrest and a putative anti-cancer effect. A second group of 12 DEGs is involved in immune response, and this gene deregulation suggests a putative anti-inflammatory effect and a strong response to bacteria and viruses. An important group of 14 DEGs (group 3) is involved in digestion and metabolism, pointing to bile acid biosynthesis, hypolipidemic and hypoglycemic effects, appetite regulation and intestinal absorption increase. In the 4th group, we noticed a stimulation of the neural and sensory development, suggested by the up-regulation of 13 genes involved in neuron differentiation and development, memory, smell and visual perception, and also in circadian rhythm regulation. The anti-xenobiotic and putative antioxidant effects were indicated by six DEGs (group 5), and finally, we found three genes involved in energy metabolism and calcium transport that were also deregulated, but their putative health effect could be less discernible (group 6). When following these profiles in the other diet conditions (Fru, CGA and STL), we observed that in the vast majority of cases, the fructose offers similar deregulation as the chicory (48 DEGs with similar profile), reflecting the importance of fructose for the functional effect of the chicory flour. CGA and STL are also involved in these deregulations, as CGA induces a similar profile as the chicory flour for 18 genes and STL also for 18 genes. We noticed only four opposite profiles between chicory flour and CGA or STL diets, probably due to the administration of these compounds apart from the food matrix. We observed that the same functions appear to be deregulated in the three analyzed tissues, even if different genes respond specifically in each of them; only two genes (Rwdd3 and Pex11a) were found similarly expressed in the liver and ileum and were separately recorded.

3.3. In Vivo Hormonal Assays

Slight differences were observed in plasmatic hormone levels following chicory flour intake. These differences were not significant in the Chic condition, but other compounds have proven to be significantly involved in these modifications. Thus, CGA decreased circulating leptin level and STL increased GIP level (Figure 2, File S4). The decrease in leptin level could be associated with a hypolipidemic effect, and GIP increase, with a hypoglycemic effect. These effects were equated with the mice body weight evolution and standard food consumption during the diets (File S1).

3.4. Metagenetic Analysis of Mice Microbiota

16S-rRNA gene-targeted metagenomic analysis was performed in the individual fecal samples of mice (n = 5) for each diet and the bacterial richness and phylogenetic composition of the microbiota were then estimated. After sequence processing, a total of 68 different operational taxonomic units (OTUs) were identified with an abundance > 0.1% and the average number of OTUs per individual was 703 ± 60 (File S5). The alpha diversity Shannon index indicated a stabilized diversity to the average of 2.8–3.5 for all sample groups, and no significant modifications were found during the Chic, Fru, CGA or STL diets (Figure 3A). Beta diversity among different conditions, as a comparison of taxa abundance, was considered by Principal Coordinate Analysis, which revealed a common but also specific effect of the chicory flour compounds (Figure 3B). Fructose impacted a larger number of taxa but CGA and STL also share an important role in these changes and present several particular effects.
The bacterial composition representing the phylum and genus relative abundance for major OTU is shown in Figure 4 and Figure 5, respectively. The most abundant phyla across all young subjects were Firmicutes, Bacteroidetes, Patescibacteria, Proteobacteria, Actinobacteria, Cyanobacteria and Desulfobacteria (Figure 4A). The most present were Firmicutes and Bacteroidetes and the ratio Firmicutes/Bacteroidetes (F/B) was found to be slightly diminished after 30 days of the chicory diet, probably due to the STL activity, as the only STL diet was found to induce a significant decrease (Figure 4B and File S6).
At the genus level, all changes observed in the relative abundance after 30 days of different treatments are represented in Figure 5. Quantitative modifications were observed in the abundance of several taxa after the different diets (Figure 5A). These modifications were closely followed as fold change of standardized abundance ratio (condition vs. control) (Figure 5B). Of the taxa, 13 were filtered for their relative abundance (>0.1%) consistently, in all samples, and presented modifications during the different diets. Six of them increased in abundance during the chicory diet, and seven of them decreased. The three analyzed compounds of the chicory flour (Fru, CGA and STL) triggered a similar increase in the relative abundance as the chicory flour for three taxa (Prevotellaceae, Lachnospiraceae bacterium A2 and Clostridium ASF356). Fructose alone impacted 5 taxa (Butyricicoccaceae UCG-009, Oscillospiraceae NK4A214, Ruminococcus, Faecalibacterium sp. UBA1819, and Enterococcaceae bacterium RF39), while CGA affected only the Erysipelotrichaceae. The results showed that, sometimes, two different classes of molecules could be involved together in changes in the abundance, as for Muribaculaceae, Coriobacteriales, Oscillospirales and Rikenella. A basic part of these results was validated by qPCR (File S7).

3.5. In Vitro Evaluation of the Apoptotic Effect

The effect of raw chicory flour decoction on apoptosis was studied by labelling HepG2 cells with Annexin V and propidium iodide and analyzed by flow cytometry. The amount of total apoptotic cells was calculated by considering both cells in early and late apoptosis (Figure 6); each value was reported to their respective control (DMEM). The chicory decoction induced a concentration-dependent increase in the number of apoptotic cells. Fru, CGA and STL were also tested separately and results showed that only STL at 75 µM and 100 µM induced a significant apoptotic effect (Figure 7).

3.6. In Vitro Anti-Inflammatory Effect

Chicory and its compounds at the highest non-cytotoxic concentration (data not shown) were screened for their anti-inflammatory activity in vitro using U937 cells, differentiated in macrophages and their capacity to secrete cytokines. Three pro-inflammatory cytokines (TNF-α, IL-8, IL-1β) were quantified in the cell media. As a control, stimulation with LPS significantly increased the secretion of TNF-α, and interleukin IL-8, (p < 0.0001) and IL-1β (p < 0.05) (Figure 8). The addition of the chicory decoction markedly reduced the secretion of all cytokines (p < 0.005) in inflamed cells. The decrease in interleukin levels seems to be due to CGA and STL effect and the reduction of TNF-α can probably be linked to the fructose effect.

3.7. In Vitro Antioxidant Effect

The antioxidant effect of the chicory flour was checked in a cell-free model for the superoxide anion and hydroxyl radical inhibition. The aqueous extracts of chicory flour triggered a significant decrease in superoxide anions, beginning from 0.5 mg·mL−1, and also a decrease in hydroxyl radicals that became significant, beginning from 1 mg·mL−1 (Figure 9).

4. Discussion

Chicory flour is a food product used in pastry and, at the same time, a functional food with multiple health benefits [2]. Several molecules or classes of molecules that enter the composition of chicory flour are possible effectors in these effects. This work was carried out to decompose the effects of chicory flour and to better understand the role of three of its components, Fru, CGA and STL. To do this, in vivo murine experimental analyses were carried out using an aqueous decoction of chicory, whose composition was found similar and quantitatively close (up to 70–80%) to that of flour. Analyses were performed to intercept nutrigenomic, hormonal and metagenomic changes that were subsequently correlated with events observed in vitro on human cells or in acellular systems.

4.1. The Anti-Cancer Effect of the Chicory Roots as Observed in an In Vivo Murine and In Vitro Human Cell Models

A chicory supplemented diet triggered the deregulation of nine genes involved in cell proliferation and apoptosis (Figure 1). In addition, this diet induced an apoptotic effect in HepG2 cells in vitro (Figure 6 and Figure 7). To determine which compound from chicory is responsible for this effect, we looked at the role of Fru, CGA and STL on gene expression and on HepG2 cells phenotype.
In liver tissue, we found two down-regulated genes under chicory treatment. The first one, Nanog, is a transcriptional factor that helps embryonic stem cells to maintain pluripotency by suppressing cell determination factors [27]. As it is highly expressed in cancer stem cells, this gene functions as an oncogene to promote carcinogenesis [28,29], being described as a prognostic and predictive cancer biomarker [30]. Its down-regulation in Chic and Fru dietary conditions suggests that chicory flour, via its fructose content, can lead to the arrest of cells engaged in cancer proliferation. The second gene in this group, Particl, is involved in the response to irradiation and affords an RNA binding platform for genomic silencers, such as DNA methyltransferase 1 and histone tri-methyltransferases, to reign in the expression of tumor suppressors [31]. This gene was correlated to the expression of tumor suppressor genes, as it operates an active feedback silencing mechanism upon the putative tumor suppressor mat2a, to limit its expression [32]. The knockdown of this gene resulted in inverse changes in Wwox transcripts levels, which is also known as coding for a tumor suppressor [33]. As we found the Particl gene down-regulated by the Chic and STL diets, we can suggest that chicory flour, via its STL content, can lead to an increase in tumor suppression, probably by apoptosis [34]. Our results on HepG2 cells indicated that only STL induced a significant apoptotic effect that could be related to Particl gene down-regulation.
In ileum cells, we found three up-regulated genes under the Chic diet. Mcmdc2 is an essential gene for meiotic recombination-mediated repair [35] and fructose seemed to be the compound responsible for its up-regulation. Mtss1 plays an important role in metastasis blocking, by governing the metastatic nature of cancer cells [36,37], and its up-regulation was led by the CGA and STL diets. Lzts1 codes for a tumor suppressor that may stabilize the active CDC2-cyclin B1 complex and thereby contributes to the regulation of the cell cycle and the prevention of uncontrolled cell proliferation [38]. All chicory compounds (Fru, CGA and STL) seemed to participate in the up-regulation of this gene.
In caecum tissue, four genes were up-regulated during the chicory diet. Anp32a codes for a protein that has been found to be decreased or absent in malignant tumors, and to modulate cell growth by regulating p38 and AKT activity [39]. Cables1 codes for a vital cell cycle regulator, dysregulation of which has been associated with a large number of human malignancies [40]. Ctbp2 codes for a negative regulator of cell proliferation, and Chtf8 is also involved in the cell cycle and, equally, in telomere maintenance via semi-conservative replication [41]. These genes were found to be up-regulated by the chicory diet, and fructose seems to be the bioactive component for all of them.
We observed that fructose plays a major role in the deregulation of genes involved in cell proliferation regulation, but CGA and STL can also impact several key genes, especially those involved in metastasis suppression. STL alone seems to be responsible for one important apoptosis-related gene expression, and this observation could be associated with in vitro results (Figure 8), showing a significant apoptotic effect of STL on HepG2 cells. Our observations are consistent with other studies showing the effect of chicory extracts on the regulation of cell proliferation and apoptosis in different human cancer cell lines [42,43].

4.2. The Anti-Inflammatory Effect as Observed in an In Vivo Murine and In Vitro Human Cell Models

All three analyzed tissues responded by an increase in the anti-inflammatory effect during the chicory diet. The liver responded by the deregulation of Snx10, Nt5e and Rwdd3, ileum, also by the Rwdd3 deregulation and the caecum by the Cfd gene deregulation (Figure 1). SNX10 presents a crucial role in macrophage polarization and inflammation, and the loss of SNX10 function was proposed to be a potentially promising therapeutic strategy for inflammatory bowel disease [44]. The down-regulation of this gene suggests an anti-inflammatory effect, triggered by the chicory flour, and among its components by the fructose only. NT5E is a marker of lymphocyte differentiation, and this enzyme contributes to the anti-inflammatory properties of afferent lymphatic endothelial cells in humans and mice [45]. Fructose, but also CGA and STL, could induce an up-regulation of the gene coding for this enzyme. RWDD3 is involved in the negative regulation of NF-κB transcription factor activity [46] and its up-regulation by the chicory diet could be attributed to the fructose in the liver. In ileum cells, in addition to fructose, CGA and STL also increased the expression of this gene. CFD is a component of the alternative complement pathway [47], involved in the inflammatory response. Its down-regulation during the chicory diet could be attributed to all analyzed compounds: fructose, CGA and STL.
An anti-inflammatory response from chicory roots has already been observed by Ripoll et al. [48] and Matos et al. [49], who investigated the immunomodulatory mechanisms of STL across the modulation of inflammatory pathways in vivo, on rat and mouse models and, respectively, in vitro, on human intestinal mucosa Caco-2 cells. Our observations in vivo were performed over nutrigenomic analyses, under chicory flour, fructose, CGA and STL supplementation (Figure 1) and indicated a deregulation of four genes involved in anti-inflammatory responses. Thereafter, our in vitro observations (Figure 8) showed that chicory supplementation in mice led to a decrease in TNF-α, IL-1β, IL-8 levels. The fructose, CGA and STL were pointed as effector molecules. CGA and STL seemed to be affecting IL-1β and IL-8 levels more, and fructose was responsible for TNF-α reduction.

4.3. Antibacterial and Antiviral Effect as Observed in an In Vivo Murine Model

During the chicory diet, seven genes involved in the antimicrobial effect and innate immune system were impacted (Figure 1). Thus, Wfdc21, Asb12, Ighv5-4, Ap1m1, Irf2bp2, Saa3 and Mzb1 were found up-regulated under the Chic diet, except Ap1m1, which was impacted by the CGA, while all the others were up-regulated by the fructose intake. The antibacterial effect of a CGA-rich extract on several common pathogens was already suggested by in vitro experiment [7] and the honey containing fructose was also described as a potential anti-bacterial agent [50].

4.4. Hypolipidemic and Hypoglycemic Effects, Appetite Regulation and Intestinal Absorption as Observed in an In Vivo Murine Model

Chicory has been described as a digestive remedy for both humans [51,52] and animals [53,54,55]. Hypolipidemic and hypoglycemic effects were already observed in mice [2]. We support these data with new in vivo nutrigenomic and hormonal effects in the present study. Liver tissue, ileum enterocytes and caecum tissue responded to the chicory flour diet by the up-regulation of seven genes, resulting in lipid metabolism modifications with, consequently, hypolipidemic effects (Apoa1, Acox3, Pex11a, Akr1b8, Fa2h and Gla), the deregulation of five genes, triggering a hypoglycemic effect and affecting the appetite regulation (Tpi1, Sp6, Gcg, Insm2, Sec11a), and also a gene playing an important role in intestinal absorption (Add1) (Figure 1).
Gene coding for APOA1, which is the major component of the high-density lipoprotein complex, playing a key role in the metabolism of triglycerides [56] and clear fats, including cholesterol [57], was found up-regulated under the CGA diet. Gene coding for ACOX3 is essential for bile acid formation [58], with a role in lipid destructuration, and was up-regulated by all chicory compounds (Fru, CGA and STL). Gene coding for LIPH, which is also involved in the triglyceride catabolism [59], and for PEX11A that is known to have a major impact on lipid metabolism [60,61], were found deregulated in both liver and ileum, being impacted by the fructose only. AKR1B8, that regulates fatty acid synthesis [62], FA2H, that is involved in galactosphingolipid synthesis [63], and GLA, that is involved in sphingolipids metabolism [64], were also impacted by all bioactive effectors: fructose, CGA and STL (Figure 1). All these deregulations could trigger a hypolipidemic effect, and this consequence is also suggested by in vivo Luminex assay (Figure 2). The circulating level of leptin was reduced after 30 days of chicory supplementation and significantly altered by the CGA diet. Being directly linked to the body fat distribution [65], a decrease in plasmatic leptin could be associated to the hypolipidemic effect. In our study, body weight was not significantly altered (Supplementary File S1), however, a slight decrease in body weight was observed for Chic fed mice.
Concerning glycemic effect, we observed that gene coding for TPI1, which is involved in glycolysis [66], and for SP6, involved in hepatic gluconeogenesis [67], were up-regulated during the chicory diet. The responsible bioactive compound seems to be the fructose that induced the same deregulation as the chicory flour when administrated alone. We know that honey containing fructose exerts a hypoglycemic effect [68], and so, obviously, the fructose contained in the chicory could act similarly.
The appetite regulation was already described as an important effect in chicory root consumption [2,18]. We found Gcg gene coding for pro-glucagon to be down-regulated. This gene, which plays a key role in glucose metabolism and homeostasis [69], was impacted by the fructose and STL. The gene coding for INSM2 that stimulates the pancreatic endocrine cell differentiation and, thus, the insulin biosynthesis [70], was up-regulated by all chicory compounds. We also found that gene coding for Sec11a, involved in incretin synthesis [71], was up-regulated under the chicory diet and that fructose seems to be the bioactive compound that impacts this gene. More than that, the circulating GIP level was increased after chicory consumption and significantly higher with STL supplementation (Figure 2). It is known that GIP is a primary incretin hormone, secreted from the intestine, to stimulate insulin secretion from pancreatic β cells and, thus, plays an important role in glucose metabolism [72].
Finally, the intestinal absorption was already observed to be impacted by a chicory supplementation [73], but the mechanism was unidentified. We found that gene coding for ADD1, which is involved in actin cytoskeleton organization [74], and consequently in various intestinal functions as cell motility, endothelial adhesion junctions, absorption, etc. [75], was up-regulated under chicory flour and, respectively, fructose bioactive action.

4.5. Neural and Sensory Development as Observed in an In Vivo Murine Model

This study highlighted the effect of chicory on the neural and sensory development by nutrigenomic analyses. A group of 13 genes was up-regulated under chicory intake (Figure 1). Among these genes, we note that the one coding for POU6F1 is involved in brain development and neural plasticity [76], NTF5 related to formation and maintenance of neuronal connections [77] and to taste development [78], MECP2 is essential for the normal function of nerve cells [79], and BICDL1 is a key component of vesicular transport in developing neurons [80]. Further, in this group, we found the gene coding for NAV2 that is involved in the development of different sensory organs [81], CLIC5, which is required for normal hearing [82], VMN1R101, OLFR1449 and OLFR1014, with a role in smell perception [83,84]. Another worth noting is the deregulation of gene coding for PAX7, which plays a role in neural crest development [85], RASGRF1, known for its role in long-term memory [86] and PIGT, described as implied in neuron differentiation [87]. Surprisingly, we also found a significant up-regulation in gene coding for NOCT, which is involved in the circadian rhythm regulation [88]. Other than Rasgrf1, which was up-regulated under CGA, and Noct, which was up-regulated under CGA bioactive impact, the rest of the genes were deregulated under fructose impact. Excess fructose consumption has been related to metabolic syndrome and obesity, and more generally, to the feeding behavior and a hunger-like state in the brain [89]. In chicory plants, the fructose is present in a low quantity in roots (3–6 mg/g dry matter depending on genotype). Its regular consumption, enclosed in the food matrix, was assimilated to a benefit as appetite booster [90] or appetite regulator [18] and the mechanism of its action could most probably interfere with genes involved in neural and sensory development.

4.6. Anti-Xenobiotic and Antioxidant Effect as Observed in Both In Vivo Murine and In Vitro Cell-Free Models

The chicory decoction triggered an up-regulation of genes involved in anti-xenobiotic and antioxidant effects, such as Abcc5, which codes for a transmembrane pump essential for the elimination of certain toxins [91], Hvcn1 and Gstm2, which are involved in the maintenance of redox homeostasis [92,93], and also several genes coding for cytochrome P450 polypeptides, such as CYP2B23, CYP2C29 and CYP3A57, that are known to be involved in xenobiotic metabolism [94]. Fructose was found to be the bioactive compound involved in this effect for four genes, but also CGA (for three genes) and STL (for one gene) (Figure 1). We also observed an important effect of the chicory decoction on the hydroxyl radical and on the superoxide anion (Figure 9). All these observations are in agreement with other studies and confirm the antioxidant effect of the chicory, most likely due to fructose, CGA and STL [6,11,95].

4.7. Microbiota Modifications

Fecal specimens were used for a 16S RNA targeted metagenomics analysis to estimate gut microbiota changes during the different diets. The alpha diversity indicates a relative homogeneity of responses, and the beta diversity indicates that the different chicory compounds trigger common, but also specific, modifications in bacterial taxa abundance (Figure 3). The ratio between the Firmicutes and Bacteroidetes phyla was calculated for different treatments, and a decrease in this ratio was registered for the Chic diet, probably due to the STL effect as the STL diet triggered a significant decrease in the F/B ratio (Figure 4). A change of F/B ratio may be important because this was described to be correlated with digestion and metabolic processes. In humans, this ratio was found to be significantly increased in patients developing type 1 diabetes and also obesity [96,97]. In mice, this ratio was already observed to be impacted by the chicory diet [2,18], which is also in accordance with our observations. In addition to this, we were able to detect that STL is the class of molecules that mostly modifies this ratio.
Daily feeding with the chicory flour decoction triggered changes in the relative abundance of several bacterial genera (Figure 5). Several taxa increased in abundance (Prevotellaceae, Lachnospiraceae bacterium A2, Clostridium ASF356, Muribaculaceae, Butyricicoccaceae UCG-009, Coriobacteriales), while others decreased (Oscillospirales, Oscillospiraceae NK4A214, Ruminococcus, Faecalibacterium sp. UBA1819, Erysipelotrichaceae, Enterococcaceae bacterium RF39, Rikenella) and these variations were tracked in Fru, CGA and STL diets to understand the role of these compounds in the different modifications.
Thus, the abundance of Prevotellaceae was found to be increased in the Chic diet and similarly impacted by all tested compounds. This gut bacterial taxon was found in humans, correlated with Parkinson’s Disease [98,99], its decrease indicating a disease state. Prevotellaceae was assigned as a psychobiotic [100], in other words, a group of beneficial bacteria that influences bacteria–brain relationships and exerts anxiolytic and antidepressant effects, characterized by changes in emotional, cognitive, systemic, and neural indices [101]. Short chain fatty acid (SCFA) producers were also recognized as psychobiotics [100], and we noticed in our study at least four bacterial taxa, known as butyrate, and other SCFA producers that were impacted by chicory flour and their abundance were found increased during fructose but also by the CGA and/or STL: Lachnospiraceae bacterium A2, Clostridium ASF356, Muribaculaceae, Butyricicoccaceae UCG-009 [102,103]. These observations go near the neural and sensory development, suggested by the nutrigenomic analysis, and suggest an improvement of neuronal functions during a chicory supplemented diet.
Coriobacteriaceae seemed to be positively affected under chicory uptake conditions and mainly influenced by fructose and CGA. These bacteria carry out functions of importance, such as the conversion of bile salts and steroids, as well as the activation of dietary polyphenols [104] and its modifications could be associated to the hypolipidemic effect of the chicory that was also observed across the nutrigenomic analysis. Our study showed that Oscillospirales, Oscillospiraceae NK4A214 and Ruminococcus taxa were negatively impacted by the chicory and fructose diets. These taxa were described as being negatively associated with high fatty liver index (FLI) and connected with the non-alcoholic fatty liver disease (NAFLD) [105,106,107], and their decrease in our study supports even more the hypolipidemic and hepatoprotector effect of the chicory, and especially of the fructose.
Faecalibacterium sp. UBA1819, a succinate-producing bacterium that was described to be involved in the increase in sleep fragmentation and blood pressure [108], was found with a diminished abundance during the chicory diet, probably due to the fructose content. This observation suggests a hypotensive effect of the chicory uptake.
The chicory diet across fructose, but also CGA and STL, triggered the decrease in the abundance of several taxa, known as mainly pathogenic or inflammatory factors, such as Erysipelotrichaceae, Enterococcaceae bacterium RF39 and Rikenella [109,110].
We can conclude for the microbiota analysis that together, these modifications in taxa composition surprisingly merged with many nutrigenomic impacts of the chicory uptake: effects on the neural development (by the psychobiotics as Prevotellaceae or different SCFAs producers increased abundance), hypolipidemic effects (by the Coriobacteriaceae increased abundance, and Oscillospirales, Oscillospiraceae NK4A214 and Ruminococcus decreased abundance), anti-inflammatory and anti-pathogenic effects (suggested by the Erysipelotrichaceae, Enterococcaceae bacterium RF39 and Rikenella decreased abundance). A hypotensive effect was also suggested by the Faecalibacterium sp. UBA1819 decreased abundance. As for the transcriptomic analyses, the fructose was found to play an important role in bacterial richness, being involved in the abundance modification of 12 bacterial taxa. The CGA was also observed to exert a noticeable influence for six taxa, and the STL for the other six taxa.

5. Conclusions

Chicory as a functional food has been studied in the form of root, transformed into flour, for pastry or bakery use, or more generally in the food industry. To identify the main effector molecules of the chicory, we split the composition of this flour into several classes of molecules. Inulin, the main component of the chicory root, has already been the subject of studies, showing its exclusively prebiotic effect [2]. In this work, fructose, CGA and STL were tested in daily administration in mice, and a set of analyses were performed. The gene expression profile of the experimental animals, following the different diets, indicated several deregulated biological functions, leading to several putative health effects: anti-cancer, anti-inflammatory, antimicrobial effect, and metabolic effect concerning bile acid biosynthesis, lipid and carbohydrate metabolism, appetite regulation and intestinal absorption. A regulatory effect has also been observed in many genes affecting neuronal and sensory development, suggesting a regulation of energy homeostasis. In addition, anti-xenobiotic and antioxidant effects were also observed. All these effects seem similar in the three different analyzed tissues, even though different genes appear to govern these responses in each tissue.
These effects were then recognized by complementary in vivo analyses, such as hormonal assay, and also by in vitro analyses on cultured cells or on acellular assays, to highlight the apoptotic, anti-inflammatory and antioxidant effects. A 16S RNA targeted metagenomic analysis completed the panel of health effects of the chicory flour and its components, and showed the role of fructose, CGA and STL in the development of several SCFA producers, with a psychobiotic role, bacteria with hypolipidemic, hepatoprotective and also a hypotensive role.
Hence, our study explicitly targeted these effects on gene expression, hormone-releasing and microbiota modifications and pointed out the role of different effector molecules contained in chicory roots: fructose, CGA and STL. All these responses are summarized in Figure 10 and File S8. Fructose seems to be the most involved in these activities, contributing to approximately 83% of all recorded responses. Almost half of the fructose effects were observed at the metabolism level and brain appetite regulation. CGA and STL have shown a specific role for all different effects, with an estimated 23 and 24% contribution, respectively. Further studies are certainly needed to test the role of other classes of molecules, as well as the defined role of the food matrix. Chicory genotype breeding and/or CRISPR-Cas9 tool [111] should be able to guide us even more quickly in the complete deciphering of different effects and effectors of chicory flour on health.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/nu14050957/s1, File S1. Mice body weight evolution (A) and standard food consumption (B) during chicory (Chic), fructose (Fru), chlorogenic acids (CGA) and sesquiterpene lactones (STL) supplemented diet for 30 days. File S2. Heatmap of metabolite signals. File S3. Gene expression profiles in mice liver tissue, ileum cells and caecum of mice during different diets. File S4. GIP and leptin level in mice plasma, after 30 days of chicory, fructose, CGA and STL diet. File S5. The operational taxonomic units (OTUs) identified with an abundance >0.1% in fecal microbiota of mice after different diets. Diets were supplemented with chicory flour (Chic), fructose (Fru), chlorogenic acids (CGA) and sesquiterpene lactones. File S6. Standardized abundance ratio (relative to D0) for Firmicutes and Bacteroidetes phyla after 30 days of diet in mice. File S7. Microbial profiling using quantitative PCR. File S8. Estimation of the most important effects of the chicory and its tested compounds: fructose (Fru), chlorogenic acids (CGA) and sesquiterpene lactones (STL).

Author Contributions

Conceptualization, A.L.-D. and B.C.; Methodology, A.L.-D., B.C., J.B., B.T. and R.M.; Formal analysis, C.L.P., A.L.-D., E.R., S.O., B.T., M.T. and D.M.; Validation, S.O.; Data curation, B.T., J.-X.F., D.M. and R.M.; Writing—Original Draft Preparation, A.L.-D. and C.L.P.; Writing—Review and Editing, B.C., C.R., J.-L.H., B.T., G.D., J.B., R.M., D.G. and D.M.; Supervision, R.R., G.D., J.-L.H., D.G. and C.R.; Project administration, C.R.; Funding acquisition, C.R. and J.-L.H. All authors have read and agreed to the published version of the manuscript.

Funding

This work has been supported by the Région des Hauts-de-France via ALIBIOTECH CPER/FEDER 2016–2021 and FEDER for CHIC41H 2019–2021 programs.

Institutional Review Board Statement

The study was conducted according to the Directive 2010/63/EEC for the protection of animals used for fine scientists and in accordance with Law 2012-10 (2012) and 2013-118 (2013). The protocol was approved by the Ethics Committee in charge of animal experiments (C2EA-75, France, date of approval: 8 September 2020).

Informed Consent Statement

Not applicable.

Data Availability Statement

Transcriptomic and metagenomics data are archived in GEO database and NCBI’s Sequence Archive and will be publicly accessible at the same time as the publication of the article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Perović, J.; Tumbas Šaponjac, V.; Kojić, J.; Krulj, J.; Moreno, D.A.; García-Viguera, C.; Bodroža-Solarov, M.; Ilić, N. Chicory (Cichorium intybus L.) as a food ingredient—Nutritional composition, bioactivity, safety, and health claims: A review. Food Chem. 2021, 336, 127676. [Google Scholar] [CrossRef] [PubMed]
  2. Pouille, C.L.; Jegou, D.; Dugardin, C.; Cudennec, B.; Ravallec, R.; Hance, P.; Rambaud, C.; Hilbert, J.L.; Lucau-Danila, A. Chicory root flour—A functional food with potential multiple health benefits evaluated in a mice model. J. Funct. Foods 2020, 74, 104174. [Google Scholar] [CrossRef]
  3. Reimer, R.A.; Soto-Vaca, A.; Nicolucci, A.C.; Mayengbam, S.; Park, H.; Madsen, K.L.; Menon, R.; Vaughan, E.E. Effect of chicory inulin-type fructan–containing snack bars on the human gut microbiota in low dietary fiber consumers in a randomized crossover trial. Am. J. Clin. Nutr. 2020, 111, 1286–1296. [Google Scholar] [CrossRef]
  4. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Frutalose®, a mixture of fructans obtained from enzymatic hydrolysis of chicory inulin, and normal defecation: Evaluation of a health claim pursuant to Article 13 of Regulation (EC) No 1924/2006. EFSA J. 2021, 19, e06775. [Google Scholar] [CrossRef]
  5. Ferrare, K.; Bidel, L.P.; Awwad, A.; Poucheret, P.; Cazals, G.; Lazennec, F.; Azay-Milhau, J.; Tournier, M.; Lajoix, A.D.; Tousch, D. Increase in insulin sensitivity by the association of chicoric acid and chlorogenic acid contained in a natural chicoric acid extract (NCRAE) of chicory (Cichorium intybus L.) for an antidiabetic effect. J. Ethnopharmacol. 2018, 215, 241–248. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Epure, A.; Pârvu, A.E.; Vlase, L.; Benedec, D.; Hanganu, D.; Gheldiu, A.M.; Toma, V.A.; Oniga, I. Phytochemical profile, antioxidant, cardioprotective and nephroprotective activity of romanian chicory extract. Plants 2021, 10, 64. [Google Scholar] [CrossRef] [PubMed]
  7. Bernard, G.; Alves Dos Santos, H.A.D.; Etienne, A.; Samaillie, J.; Neut, C.; Sahpaz, S.; Hilbert, J.L.; Gagneul, D.; Jullian, N.; Tahrioui, A.; et al. MeJA elicitation of chicory hairy roots promotes efficient increase of 3,5-diCQA accumulation, a potent antioxidant and antibacterial molecule. Antibiotics 2020, 9, 659. [Google Scholar] [CrossRef]
  8. Peña-Espinoza, M.; Williams, A.R.; Thamsborg, S.M.; Simonsen, H.T.; Enemark, H.L. Anthelmintic effects of forage chicory (Cichorium intybus) against free-living and parasitic stages of Cooperia oncophora. Vet. Parasitol. 2017, 243, 204–207. [Google Scholar] [CrossRef] [Green Version]
  9. Peña-Espinoza, M.; Valente, A.H.; Bornancin, L.; Simonsen, H.T.; Thamsborg, S.M.; Williams, A.R.; López-Muñoz, R. Anthelmintic and metabolomic analyses of chicory (Cichorium intybus) identify an industrial by-product with potent in vitro antinematodal activity. Vet. Parasitol. 2020, 280, 109088. [Google Scholar] [CrossRef]
  10. Valente, A.H.; de Roode, M.; Ernst, M.; Peña-Espinoza, M.; Bornancin, L.; Bonde, C.S.; Martínez-Valladares, M.; Ramünke, S.; Krücken, J.; Simonsen, H.T.; et al. Identification of compounds responsible for the anthelmintic effects of chicory (Cichorium intybus) by molecular networking and bio-guided fractionation. Int. J. Parasitol. Drugs Drug Resist. 2021, 15, 105–114. [Google Scholar] [CrossRef]
  11. Karadeniz, F.; Oh, J.H.; Kong, C.-S. Sesquiterpene lactones: A review of biological activities. J. Life Sci. 2021, 31, 430–441. [Google Scholar] [CrossRef]
  12. Matos, M.S.; Anastácio, J.D.; Santos, C.N.D. Sesquiterpene lactones: Promising natural compounds to fight inflammation. Pharmaceutics 2021, 13, 991. [Google Scholar] [CrossRef]
  13. Abbas, Z.K.; Saggu, S.; Sakeran, M.I.; Zidan, N.; Rehman, H.; Ansari, A.A. Phytochemical, antioxidant and mineral composition of hydroalcoholic extract of chicory (Cichorium intybus L.) leaves. Saudi J. Biol. Sci. 2015, 22, 322–326. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Hoste, H.; Jackson, F.; Athanasiadou, S.; Thamsborg, S.M.; Hoskin, S.O. The effects of tannin-rich plants on parasitic nematodes in ruminants. Trends Parasitol. 2006, 22, 253–261. [Google Scholar] [CrossRef] [PubMed]
  15. Tchoumtchoua, J.; Mathiron, D.; Pontarin, N.; Gagneul, D.; van Bohemen, A.-I.; Otogo N’nang, E.; Mesnard, F.; Petit, E.; Fontaine, J.-X.; Molinié, R.; et al. Phenolic profiling of flax highlights contrasting patterns in winter and spring varieties. Molecules 2019, 24, 4303. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Deborde, C.; Fontaine, J.-X.; Jacob, D.; Botana, A.; Nicaise, V.; Richard-Forget, F.; Lecomte, S.; Decourtil, C.; Hamade, K.; Mesnard, F.; et al. Optimizing 1D 1H-NMR profiling of plant samples for high throughput analysis: Extract preparation, standardization, automation and spectra processing. Metabolomics 2019, 15, 28. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Jacob, D.; Deborde, C.; Lefebvre, M.; Maucourt, M.; Moing, A. NMRProcFlow: A graphical and interactive tool dedicated to 1D spectra processing for NMR-based metabolomics. Metabolomics 2017, 13, 36. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Fouré, M.; Dugardin, C.; Foligné, B.; Hance, P.; Cadalen, T.; Delcourt, A.; Taminiau, B.; Daube, G.; Ravallec, R.; Cudennec, B.; et al. Chicory roots for prebiotics and appetite regulation: A pilot study in mice. J. Agric. Food Chem. 2018, 66, 6439–6449. [Google Scholar] [CrossRef] [Green Version]
  19. Willeman, H. Contribution à la Recherche des Composés Impliqués dans L’amertume de la Racine de Chicorée: Approches Métabolomique et Sensorielle de L’influence de la Torréfaction. Ph.D. Thesis, University of Lille, Lille, France, 2016. Available online: https://www.theses.fr/2016LIL10222 (accessed on 21 January 2022).
  20. Obafemi, C.A.; Sulaimon, T.O.; Akinpelu, D.A.; Olugbade, T.A. Antimicrobial activity of extracts and a germacranolidetype sesquiterpene lactone from Tithonia diversifolia leaf extract. Afr. J. Biotechnol. 2006, 5, 1254–1258. [Google Scholar] [CrossRef]
  21. Passos, C.P.; Costa, R.M.; Ferreira, S.S.; Lopes, G.R.; Cruz, M.T.; Coimbra, M.A. Role of coffee caffeine and chlorogenic acids adsorption to polysaccharides with impact on brew immunomodulation effects. Foods 2021, 10, 378. [Google Scholar] [CrossRef]
  22. Rognes, T.; Flouri, T.; Nichols, B.; Quince, C.; Mahé, F. VSEARCH: A versatile open source tool for metagenomics. Peer J. 2016, 4, e2584. [Google Scholar] [CrossRef] [PubMed]
  23. Gérard, A.; El-Hajjaji, S.; Burteau, S.; Fall, P.A.; Pirard, B.; Taminiau, B.; Daube, G.; Sindic, M. Study of the microbial diversity of a panel of Belgian artisanal cheeses associated with challenge studies for Listeria monocytogenes. Food Microbiol. 2021, 100, 103861. [Google Scholar] [CrossRef] [PubMed]
  24. Ma, X.; Tian, X.; Huang, X.; Yan, F.; Qiao, D. Resveratrol-induced mitochondrial dysfunction and apoptosis are associated with Ca2+ and mCICR-mediated MPT activation in HepG2 cells. Mol. Cell. Biochem. 2007, 302, 99–109. [Google Scholar] [CrossRef] [PubMed]
  25. Aruoma, O.I.; Halliwell, B.; Hoey, B.M.; Butler, J. The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radical Biol. Med. 1989, 6, 593–597. [Google Scholar] [CrossRef]
  26. Halliwell, B.; Gutteridge, J.M.; Aruoma, O.I. The deoxyribose method: A simple “test-tube” assay for determination of rate constants for reactions of hydroxyl radicals. Anal. Biochem. 1987, 165, 215–219. [Google Scholar] [CrossRef]
  27. Heurtier, V.; Owens, N.; Gonzalez, I.; Mueller, F.; Proux, C.; Mornico, D.; Clerc, P.; Dubois, A.; Navarro, P. The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells. Nat. Commun. 2019, 10, 1109. [Google Scholar] [CrossRef] [Green Version]
  28. Gong, S.; Li, Q.; Jeter, C.R.; Fan, Q.; Tang, D.G.; Liu, B. Regulation of NANOG in cancer cells. Mol. Carcinog. 2015, 54, 679–687. [Google Scholar] [CrossRef] [Green Version]
  29. Gawlik-Rzemieniewska, N.; Bednarek, I. The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells. Cancer Biol. Ther. 2016, 17, 1–10. [Google Scholar] [CrossRef] [Green Version]
  30. Santaliz-Ruiz, L.E.; Xie, X.; Old, M.; Teknos, T.N.; Pan, Q. Emerging role of nanog in tumorigenesis and cancer stem cells. Int. J. Cancer 2014, 135, 2741–2748. [Google Scholar] [CrossRef]
  31. O’Leary, V.B.; Ovsepian, S.V.; Smida, J.; Atkinson, M.J. PARTICLE–The RNA podium for genomic silencers. J. Cell. Physiol. 2019, 234, 19464–19470. [Google Scholar] [CrossRef]
  32. O’Leary, V.B.; Hain, S.; Maugg, D.; Smida, J.; Azimzadeh, O.; Tapio, S.; Ovsepian, S.V.; Atkinson, M.J. Long non-coding RNA PARTICLE bridges histone and DNA methylation. Sci. Rep. 2017, 7, 1790. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. O’Leary, V.B.; Smida, J.; Buske, F.A.; Carrascosa, L.G.; Azimzadeh, O.; Maugg, D.; Hain, S.; Tapio, S.; Heidenreich, W.; Kerr, J.; et al. PARTICLE triplexes cluster in the tumor suppressor WWOX and may extend throughout the human genome. Sci. Rep. 2017, 7, 7163. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Delbridge, A.R.D.; Valente, L.J.; Strasser, A. The role of the apoptotic machinery in tumor suppression. Cold Spring Harbor Perspect. Biol. 2012, 4, a008789. [Google Scholar] [CrossRef] [PubMed]
  35. Finsterbusch, F.; Ravindranathan, R.; Dereli, I.; Stanzione, M.; Tränkner, D.; Tóth, A. Alignment of homologous chromosomes and effective repair of programmed DNA double-strand breaks during mouse meiosis require the minichromosome maintenance domain containing 2 (MCMDC2) protein. PLoS Genet. 2016, 12, e1006393. [Google Scholar] [CrossRef] [Green Version]
  36. Parr, C.; Jiang, W.G. Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer. Eur. J. Cancer 2009, 45, 1673–1683. [Google Scholar] [CrossRef] [PubMed]
  37. Du, P.; Ye, L.; Yang, Y.; Jiang, W.G. The tumour suppressive role of metastasis suppressor-1, MTSS1, in human kidney cancer, a possible connection with the SHH pathway. J. Exp. Ther. Oncol. 2012, 10, 91–99. [Google Scholar]
  38. Wang, X.X.; Liu, B.B.; Wu, X.; Su, D.; Zhu, Z.; Fu, L. Loss of leucine zipper putative tumor suppressor 1 (LZTS1) expression contributes to lymph node metastasis of breast invasive micropapillary carcinoma. Pathol. Oncol. Res. 2015, 21, 1021–1026. [Google Scholar] [CrossRef] [Green Version]
  39. Yan, W.; Bai, Z.; Wang, J.; Li, X.; Chi, B.; Chen, X. ANP32A modulates cell growth by regulating p38 and Akt activity in colorectal cancer. Oncol. Rep. 2017, 38, 1605–1612. [Google Scholar] [CrossRef] [Green Version]
  40. Shi, Z.; Li, Z.; Li, Z.J.; Cheng, K.; Du, Y.; Fu, H.; Khuri, F.R. Cables1 controls p21/Cip1 protein stability by antagonizing proteasome subunit alpha type 3. Oncogene 2015, 34, 2538–2545. [Google Scholar] [CrossRef] [Green Version]
  41. Murakami, T.; Takano, R.; Takeo, S.; Taniguchi, R.; Ogawa, K.; Ohashi, E.; Tsurimoto, T. Stable interaction between the human proliferating cell nuclear antigen loader complex Ctf18-replication factor C (RFC) and DNA polymerase ϵ is mediated by the cohesion-specific subunits, Ctf18, Dcc1, and Ctf8. J. Biol. Chem. 2010, 285, 34608–34615. [Google Scholar] [CrossRef] [Green Version]
  42. Saleem, M.; Abbas, K.; Naseer, F.; Ahmad, M.; Syed, N.H.; Javed, F.; Hussain, K.; Asima, S. Anticancer activity of n-hexane extract of Cichorium intybus on lymphoblastic leukemia cells (Jurkat cells). Afr. J. Plant Sci. 2014, 8, 315–319. [Google Scholar] [CrossRef] [Green Version]
  43. Mehrandish, R.; Awsat Mellati, A.; Rahimipour, A.; Dehghan Nayeri, N. Anti-cancer activity of methanol extracts of Cichorium intybus on human breast cancer SKBR3 cell line. Razavi Int. J. Med. 2016, 5, 1–4. [Google Scholar] [CrossRef]
  44. You, Y.; Zhou, C.; Li, D.; Cao, Z.L.; Shen, W.; Li, W.Z.; Zhang, S.; Hu, B.; Shen, X. Sorting nexin 10 acting as a novel regulator of macrophage polarization mediates inflammatory response in experimental mouse colitis. Sci. Rep. 2016, 6, 20630. [Google Scholar] [CrossRef] [PubMed]
  45. Eichin, D.; Pessia, A.; Takeda, A.; Laakkonen, J.; Bellmann, L.; Kankainen, M.; Imhof, B.A.; Stoitzner, P.; Tang, J.; Salmi, M.; et al. CD73 contributes to anti-inflammatory properties of afferent lymphatic endothelial cells in humans and mice. Eur. J. Immunol. 2021, 51, 231–246. [Google Scholar] [CrossRef] [PubMed]
  46. Liu, B.; Yang, R.; Wong, K.A.; Getman, C.; Stein, N.; Teitell, M.A.; Cheng, G.; Wu, H.; Shuai, K. Negative regulation of NF-κB signaling by PIAS1. Mol. Cell Biol. 2005, 25, 1113–1123. [Google Scholar] [CrossRef] [Green Version]
  47. Narayana, S.V.; Carson, M.; el-Kabbani, O.; Kilpatrick, J.M.; Moore, D.; Chen, X.; Bugg, C.E.; Volanakis, J.E.; DeLucas, L.J. Structure of human factor D. A complement system protein at 2.0 A resolution. J. Mol. Biol. 1994, 235, 695–708. [Google Scholar] [CrossRef]
  48. Ripoll, C.; Schmidt, B.M.; Ilic, N.; Poulev, A.; Dey, M.; Kurmukov, A.G.; Raskin, I. Anti-inflammatory effects of a sesquiterpene lactone extract from chicory (Cichorium intybus L.) roots. Nat. Prod. Commun. 2007, 2, 1934578X0700200. [Google Scholar] [CrossRef] [Green Version]
  49. Matos, M.S.; Anastácio, J.D.; Allwood, J.W.; Carregosa, D.; Marques, D.; Sungurtas, J.; McDougall, G.J.; Menezes, R.; Matias, A.A.; Stewart, D.; et al. Assessing the intestinal permeability and anti-inflammatory potential of sesquiterpene lactones from chicory. Nutrients 2020, 12, 3547. [Google Scholar] [CrossRef]
  50. Meo, S.A.; Al-Asiri, S.A.; Mahesar, A.L.; Ansari, M.J. Role of honey in modern medicine. Saudi J. Biol. Sci. 2017, 24, 975–978. [Google Scholar] [CrossRef]
  51. Nowrouzi, P.; Mazani, M.; Rezagholizadeh, L.; Banaei, S. Mechanism and clinical aspects of the effects of chicory on diabetes. Asian J. Res. Med. Pharm. Sci. 2017, 1, 1–11. [Google Scholar] [CrossRef]
  52. Nishimura, M.; Ohkawara, T.; Kanayama, T.; Kitagawa, K.; Nishimura, H.; Nishihira, J. Effects of the extract from roasted chicory (Cichorium intybus L.) root containing inulin-type fructans on blood glucose, lipid metabolism, and fecal properties. J. Tradit. Complement. Med. 2015, 5, 161–167. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Minneé, E.; Waghorn, G.; Lee, J.; Clark, C. Including chicory or plantain in a perennial ryegrass/white clover-based diet of dairy cattle in late lactation: Feed intake, milk production and rumen digestion. Anim. Feed Sci. Technol. 2017, 227, 52–61. [Google Scholar] [CrossRef]
  54. Niderkorn, V.; Martin, C.; Bernard, M.; le Morvan, A.; Rochette, Y.; Baumont, R. Effect of increasing the proportion of chicory in forage-based diets on intake and digestion by sheep. Animal 2019, 13, 718–726. [Google Scholar] [CrossRef] [PubMed]
  55. Khoobani, M.; Hasheminezhad, S.H.; Javandel, F.; Nosrati, M.; Seidavi, A.; Kadim, I.T.; Laudadio, V.; Tufarelli, V. Effects of dietary chicory (Chicorium intybus L.) and probiotic blend as natural feed additives on performance traits, blood biochemistry, and gut microbiota of broiler chickens. Antibiotics 2019, 9, 5. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Chien, K.L.; Fang, W.H.; Wen, H.C.; Lin, H.P.; Lin, Y.L.; Lin, S.W.; Wu, J.H.; Kao, J.T. APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese. Clin. Chim. Acta 2008, 390, 56–62. [Google Scholar] [CrossRef]
  57. Plump, A.S.; Azrolan, N.; Odaka, H.; Wu, L.; Jiang, X.; Tall, A.; Eisenberg, S.; Breslow, J.L. ApoA-I knockout mice: Characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes. J. Lipid Res. 1997, 38, 1033–1047. [Google Scholar] [CrossRef]
  58. Vanhooren, J.C.T.; Fransen, M.; Bethune, B.; Baumgart, E.; Baes, M.; Torrekens, S.; Leuven, F.; Mannaerts, G.P.; Veldhoven, P.P. Rat Pristanoyl-CoA Oxidase. cDNA Cloning and recognition of its C-Terminal (SQL) by the peroxisomal-targeting signal 1 receptor. Eur. J. Biochem. 1996, 239, 302–309. [Google Scholar] [CrossRef]
  59. Aoki, J.; Inoue, A.; Okudaira, S. Two pathways for lysophosphatidic acid production. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2008, 1781, 513–518. [Google Scholar] [CrossRef]
  60. Chen, C.; Wang, H.; Chen, B.; Chen, D.; Lu, C.; Li, H.; Qian, Y.; Tan, Y.; Weng, H.; Cai, L. Pex11a deficiency causes dyslipidaemia and obesity in mice. J. Cell. Mol. Med. 2018, 23, 2020–2031. [Google Scholar] [CrossRef]
  61. Weng, H.; Ji, X.; Naito, Y.; Endo, K.; Ma, X.; Takahashi, R.; Shen, C.; Hirokawa, G.; Fukushima, Y.; Iwai, N. Pex11α deficiency impairs peroxisome elongation and division and contributes to nonalcoholic fatty liver in mice. Am. J. Physiol. Endocrinol. Metab. 2013, 304, E187–E196. [Google Scholar] [CrossRef] [Green Version]
  62. Joshi, A.; Rajput, S.; Wang, C.; Ma, J.; Cao, D. Murine aldo-keto reductase family 1 subfamily B: Identification of AKR1B8 as an ortholog of human AKR1B10. Biol. Chem. 2010, 391, 1371–1378. [Google Scholar] [CrossRef] [PubMed]
  63. Zoöller, I.; Meixner, M.; Hartmann, D.; Bussow, H.; Meyer, R.; Gieselmann, V.; Eckhardt, M. Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration. J. Neurosci. 2008, 28, 9741–9754. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Garman, S.C.; Garboczi, D.N. The molecular defect leading to Fabry disease: Structure of human α-galactosidase. J. Mol. Biol. 2004, 337, 319–335. [Google Scholar] [CrossRef] [PubMed]
  65. Prolo, P.; Wong, M.L.; Licinio, J. Leptin. Int. J. Biochem. Cell Biol. 1998, 30, 1285–1290. [Google Scholar] [CrossRef]
  66. van Wijk, R.; van Solinge, W.W. The energy-less red blood cell is lost: Erythrocyte enzyme abnormalities of glycolysis. Blood 2005, 106, 4034–4042. [Google Scholar] [CrossRef]
  67. Wang, L.; Tong, X.; Gu, F.; Zhang, L.; Chen, W.; Cheng, X.; Xie, L.; Chang, Y.; Zhang, H. The KLF14 transcription factor regulates hepatic gluconeogenesis in mice. J. Biol. Chem. 2017, 292, 21631–21642. [Google Scholar] [CrossRef] [Green Version]
  68. Erejuwa, O.O.; Sulaiman, S.A.; Wahab, M.S.A. Fructose might contribute to the hypoglycemic effect of honey. Molecules 2012, 17, 1900–1915. [Google Scholar] [CrossRef] [Green Version]
  69. Jin, T. Mechanisms underlying proglucagon gene expression. J. Endocrinol. 2008, 198, 17–28. [Google Scholar] [CrossRef]
  70. Cai, T.; Chen, X.; Wang, R.; Xu, H.; You, Y.; Zhang, T.; Lan, M.S.; Notkins, A.L. Expression of insulinoma-associated 2 (INSM2) in pancreatic islet cells is regulated by the transcription factors Ngn3 and NeuroD1. Endocrinology 2011, 152, 1961–1969. [Google Scholar] [CrossRef] [Green Version]
  71. Jassal, B.; Matthews, L.; Viteri, G.; Gong, C.; Lorente, P.; Fabregat, A.; Sidiropoulos, K.; Cook, J.; Gillespie, M.; Haw, R.; et al. The reactome pathway knowledgebase. Nucleic Acids Res. 2020, 48, D498–D503. [Google Scholar] [CrossRef]
  72. Seino, Y.; Fukushima, M.; Yabe, D. GIP and GLP-1, the two incretin hormones: Similarities and differences. J. Diabetes Investig. 2010, 1, 8–23. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  73. Lepczyński, A.; Herosimczyk, A.; Ożgo, M.; Barszcz, M.; Taciak, M.; Skomiał, J. Modification of ileal proteome in growing pigs by dietary supplementation with inulin or dried chicory root. J. Anim. Feed Sci. 2019, 28, 177–186. [Google Scholar] [CrossRef]
  74. Matsuoka, Y.; Li, X.; Bennett, V. Adducin: Structure, function and regulation. Cell. Mol. Life Sci. 2000, 57, 884–895. [Google Scholar] [CrossRef] [PubMed]
  75. Kiang, K.M.Y.; Leung, G.K.K. A review on adducin from functional to pathological mechanisms: Future direction in cancer. BioMed Res. Int. 2018, 2018, 3465929. [Google Scholar] [CrossRef] [PubMed]
  76. McClard, C.K.; Kochukov, M.Y.; Herman, I.; Liu, Z.; Eblimit, A.; Moayedi, Y.; Ortiz-Guzman, J.; Colchado, D.; Pekarek, B.; Panneerselvam, S.; et al. POU6f1 mediates neuropeptide-dependent plasticity in the adult brain. J. Neurosci. 2018, 38, 1443–1461. [Google Scholar] [CrossRef]
  77. Berkemeier, L.R.; Winslow, J.W.; Kaplan, D.R.; Nikolics, K.; Goeddel, D.V.; Rosenthal, A. Neurotrophin-5: A novel neurotrophic factor that activates trk and trkB. Neuron 1991, 7, 857–866. [Google Scholar] [CrossRef]
  78. Liebl, D.J.; Mbiene, J.P.; Parada, L.F. NT4/5 mutant mice have deficiency in gustatory papillae and taste bud formation. Dev. Biol. 1999, 213, 378–389. [Google Scholar] [CrossRef]
  79. Moretti, P.; Levenson, J.M.; Battaglia, F.; Atkinson, R.; Teague, R.; Antalffy, B.; Armstrong, D.; Arancio, O.; Sweatt, J.D.; Zoghbi, H.Y. Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J. Neurosci. 2006, 26, 319–327. [Google Scholar] [CrossRef] [Green Version]
  80. Schlager, M.A.; Kapitein, L.C.; Grigoriev, I.; Burzynski, G.M.; Wulf, P.S.; Keijzer, N.; de Graaff, E.; Fukuda, M.; Shepherd, I.T.; Akhmanova, A.; et al. Pericentrosomal targeting of Rab6 secretory vesicles by bicaudal-D-related protein 1 (BICDR-1) regulates neuritogenesis. EMBO J. 2010, 29, 1637–1651. [Google Scholar] [CrossRef] [Green Version]
  81. Peeters, P.J.; Baker, A.; Goris, I.; Daneels, G.; Verhasselt, P.; Luyten, W.H.; Geysen, J.J.; Kass, S.U.; Moechars, D.W. Sensory deficits in mice hypomorphic for a mammalian homologue of unc-53. Dev. Brain Res. 2004, 150, 89–101. [Google Scholar] [CrossRef]
  82. Seco, C.Z.; Oonk, A.M.; Domínguez-Ruiz, M.; Draaisma, J.M.; Gandía, M.; Oostrik, J.; Neveling, K.; Kunst, H.P.; Hoefsloot, L.H.; del Castillo, I.; et al. Progressive hearing loss and vestibular dysfunction caused by a homozygous nonsense mutation in CLIC5. Eur. J. Hum. Genet. 2014, 23, 189–194. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  83. Shirokova, E.; Raguse, J.D.; Meyerhof, W.; Krautwurst, D. The human vomeronasal type-1 receptor family—Detection of volatiles and cAMP signaling in HeLa/Olf cells. FASEB J. 2008, 22, 1416–1425. [Google Scholar] [CrossRef] [PubMed]
  84. Young, J.M.; Shykind, B.M.; Lane, R.P.; Tonnes-Priddy, L.; Ross, J.A.; Walker, M.; Williams, E.M.; Trask, B.J. Odorant receptor expressed sequence tags demonstrate olfactory expression of over 400 genes, extensive alternate splicing and unequal expression levels. Genome Biol. 2003, 4, R71. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Basch, M.L.; Bronner-Fraser, M.; García-Castro, M.I. Specification of the neural crest occurs during gastrulation and requires Pax7. Nature 2006, 441, 218–222. [Google Scholar] [CrossRef] [PubMed]
  86. Barman, A.; Assmann, A.; Richter, S.; Soch, J.; Schütze, H.; Wüstenberg, T.; Deibele, A.; Klein, M.; Richter, A.; Behnisch, G.; et al. Genetic variation of the RASGRF1 regulatory region affects human hippocampus-dependent memory. Front. Hum. Neurosci. 2014, 8, 260. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  87. Li, H.L.; Li, Z.; Qin, L.Y.; Liu, S.; Lau, L.T.; Han, J.S.; Yu, A.C.H. The novel neurotrophin-regulated neuronal development-associated protein, NDAP, mediates apoptosis. FEBS Lett. 2006, 580, 1723–1728. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  88. Niu, S.; Shingle, D.L.; Garbarino-Pico, E.; Kojima, S.; Gilbert, M.; Green, C.B. The circadian deadenylase nocturnin is necessary for stabilization of the iNOS mRNA in mice. PLoS ONE 2011, 6, e26954. [Google Scholar] [CrossRef]
  89. Payant, M.A.; Chee, M.J. Neural mechanisms underlying the role of fructose in overfeeding. Neurosci. Biobehav. Rev. 2021, 128, 346–357. [Google Scholar] [CrossRef]
  90. Wijlens, A.; Mars, M.; Dull, D.; de Graaf, K. Short term effect of chicory root fibre on appetite ratings and energy intake. Appetite 2013, 71, 490. [Google Scholar] [CrossRef]
  91. Crean, D.; Bellwon, P.; Aschauer, L.; Limonciel, A.; Moenks, K.; Hewitt, P.; Schmidt, T.; Herrgen, K.; Dekant, W.; Lukas, A.; et al. Development of an in vitro renal epithelial disease state model for xenobiotic toxicity testing. Toxicol. Vitr. 2015, 30, 128–137. [Google Scholar] [CrossRef]
  92. Capasso, M.; Bhamrah, M.K.; Henley, T.; Boyd, R.S.; Langlais, C.; Cain, K.; Dinsdale, D.; Pulford, K.; Khan, M.; Musset, B.; et al. HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species. Nat. Immunol. 2010, 11, 265–272. [Google Scholar] [CrossRef] [PubMed]
  93. Zhou, S.G.; Wang, P.; Pi, R.B.; Gao, J.; Fu, J.J.; Fang, J.; Qin, J.; Zhang, H.J.; Li, R.F.; Chen, S.R.; et al. Reduced expression of GSTM2 and increased oxidative stress in spontaneously hypertensive rat. Mol. Cell. Biochem. 2008, 309, 99–107. [Google Scholar] [CrossRef] [PubMed]
  94. Tornio, A.; Backman, J.T. Cytochrome P450 in pharmacogenetics: An update. Adv. Pharmacol. 2018, 83, 3–32. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  95. Jasim, R.S. Antioxidant, antimicrobial activities and phytochemical constituents of Cichorium intybus L. Aerial Parts. Int. J. Bot. 2018, 14, 24–29. [Google Scholar] [CrossRef]
  96. Turnbaugh, P.J.; Bäckhed, F.; Fulton, L.; Gordon, J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008, 3, 213–223. [Google Scholar] [CrossRef] [Green Version]
  97. Wen, L.; Ley, R.E.; Volchkov, P.Y.; Stranges, P.B.; Avanesyan, L.; Stonebraker, A.C.; Hu, C.; Wong, F.S.; Szot, G.L.; Bluestone, J.A.; et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008, 455, 1109–1113. [Google Scholar] [CrossRef]
  98. Braak, H.; de Vos, R.A.; Bohl, J.; del Tredici, K. Gastric α-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci. Lett. 2006, 396, 67–72. [Google Scholar] [CrossRef]
  99. Jin, M.; Li, J.; Liu, F.; Lyu, N.; Wang, K.; Wang, L.; Liang, S.; Tao, H.; Zhu, B.; Alkasir, R. Analysis of the gut microflora in patients with Parkinson’s disease. Front. Neurosci. 2019, 13, 1184. [Google Scholar] [CrossRef] [Green Version]
  100. Trzeciak, P.; Herbet, M. Role of the Intestinal microbiome, intestinal barrier and psychobiotics in depression. Nutrients 2021, 13, 927. [Google Scholar] [CrossRef]
  101. Sarkar, A.; Lehto, S.M.; Harty, S.; Dinan, T.G.; Cryan, J.F.; Burnet, P.W. Psychobiotics and the manipulation of bacteria–gut–brain signals. Trends Neurosci. 2016, 39, 763–781. [Google Scholar] [CrossRef] [Green Version]
  102. Medlock, G.L.; Carey, M.A.; McDuffie, D.G.; Mundy, M.B.; Giallourou, N.; Swann, J.R.; Kolling, G.L.; Papin, J.A. Inferring metabolic mechanisms of interaction within a defined gut microbiota. Cell Syst. 2018, 7, 245–257.e7. [Google Scholar] [CrossRef] [Green Version]
  103. Ignacio, A.; Fernandes-Terra, F.; Watanabe, I.; Basso, P.J.; Câmara, N. Role of the microbiome in intestinal barrier function and immune defense. In Microbiome and Metabolome in Diagnosis, Therapy, and Other Strategic Applications, 1st ed.; Faintuch, J., Faintuch, S., Eds.; Academic Press: Boston, MA, USA, 2019; pp. 127–138. [Google Scholar] [CrossRef]
  104. Clavel, T.; Lepage, P.; Charrier, C. The family Coriobacteriaceae. In The Prokaryotes, 1st ed.; Rosenberg, E., DeLong, E.F., Lory, S., Stackebrandt, E., Thompson, F., Eds.; Springer: Berlin/Heidelberg, Germany, 2014; pp. 201–238. [Google Scholar] [CrossRef]
  105. Kim, H.N.; Joo, E.J.; Cheong, H.S.; Kim, Y.; Kim, H.L.; Shin, H.; Chang, Y.; Ryu, S. Gut microbiota and risk of persistent nonalcoholic fatty liver diseases. J. Clin. Med. 2019, 8, 1089. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  106. Liu, G.; Zhao, Q.; Wei, H. Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis. Ann. Hepatol. 2019, 18, 796–803. [Google Scholar] [CrossRef]
  107. Ruuskanen, M.O.; Åberg, F.; Männistö, V.; Havulinna, A.S.; Méric, G.; Liu, Y.; Loomba, R.; Vázquez-Baeza, Y.; Tripathi, A.; Valsta, L.M.; et al. Links between gut microbiome composition and fatty liver disease in a large population sample. Gut Microbes 2021, 13, 1–22. [Google Scholar] [CrossRef] [PubMed]
  108. Maki, K.A.; Burke, L.A.; Calik, M.W.; Watanabe-Chailland, M.; Sweeney, D.; Romick-Rosendale, L.E.; Green, S.J.; Fink, A.M. Sleep fragmentation increases blood pressure and is associated with alterations in the gut microbiome and fecal metabolome in rats. Physiol. Genom. 2020, 52, 280–292. [Google Scholar] [CrossRef]
  109. Kaakoush, N.O. Insights into the role of Erysipelotrichaceae in the human host. Front. Cell. Infect. Microbiol. 2015, 5, 84. [Google Scholar] [CrossRef] [Green Version]
  110. Dinh, D.M.; Volpe, G.E.; Duffalo, C.; Bhalchandra, S.; Tai, A.K.; Kane, A.V.; Wanke, C.A.; Ward, H.D. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. J. Infect. Dis. 2015, 211, 19–27. [Google Scholar] [CrossRef] [Green Version]
  111. Bernard, G.; Gagneul, D.; Alves Dos Santos, H.; Etienne, A.; Hilbert, J.L.; Rambaud, C. Efficient genome editing using CRISPR/Cas9 technology in chicory. Int. J. Mol. Sci. 2019, 20, 1155. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Gene expression profiles in hepatic tissue, ileum cells and caecum of mice after different diets. Log2 fold change of gene expression was represented individually for mice (1–3) and gene-related physiological processes and putative health effect are represented on the right part of the graph. Chic—chicory flour diet; Fru—fructose diet; CGA—chlorogenic acids treatment; STL—sesquiterpene lactones treatment.
Figure 1. Gene expression profiles in hepatic tissue, ileum cells and caecum of mice after different diets. Log2 fold change of gene expression was represented individually for mice (1–3) and gene-related physiological processes and putative health effect are represented on the right part of the graph. Chic—chicory flour diet; Fru—fructose diet; CGA—chlorogenic acids treatment; STL—sesquiterpene lactones treatment.
Nutrients 14 00957 g001
Figure 2. Leptin (A) and GIP (B) level in mice plasma after 30 days of chicory, fructose, CGA and STL supplemented diet. Control values were pooled together (Ctr). Plasmatic hormone levels were expressed as a ratio of the control level. Statistical analysis was performed using one-way ANOVA and Dunnett’s multiple comparisons test (* p < 0.05; ** p < 0.01 against control).
Figure 2. Leptin (A) and GIP (B) level in mice plasma after 30 days of chicory, fructose, CGA and STL supplemented diet. Control values were pooled together (Ctr). Plasmatic hormone levels were expressed as a ratio of the control level. Statistical analysis was performed using one-way ANOVA and Dunnett’s multiple comparisons test (* p < 0.05; ** p < 0.01 against control).
Nutrients 14 00957 g002
Figure 3. Microbial diversity in fecal microbiota of mice after chicory (Chic), fructose (Fru), chlorogenic acids (CGA) or sesquiterpene lactones (STL) supplemented diet. (A) Alpha diversity was illustrated by the Shannon index (IS) that indicates a stabilized diversity for all subject groups (p > 0.05). (B) Principal Coordinates Analysis (PCoA) plots (beta-diversity) of affected taxa during different diets. Relative abundance obtained from sequencing the 16s rRNA gene in fecal samples was represented for taxa providing differences during chicory flour diet. Red circle mainly delimits the fructose effect, blue circle delimits the STL effect and green circle the CGA effect.
Figure 3. Microbial diversity in fecal microbiota of mice after chicory (Chic), fructose (Fru), chlorogenic acids (CGA) or sesquiterpene lactones (STL) supplemented diet. (A) Alpha diversity was illustrated by the Shannon index (IS) that indicates a stabilized diversity for all subject groups (p > 0.05). (B) Principal Coordinates Analysis (PCoA) plots (beta-diversity) of affected taxa during different diets. Relative abundance obtained from sequencing the 16s rRNA gene in fecal samples was represented for taxa providing differences during chicory flour diet. Red circle mainly delimits the fructose effect, blue circle delimits the STL effect and green circle the CGA effect.
Nutrients 14 00957 g003
Figure 4. Changes in bacterial phyla abundance. (A) Relative abundance (%) of phyla in mice microbiota before (D0) and after 30 days (D30) of chicory (Chic), fructose (Fru), chlorogenic acids (CGA) or sesquiterpene lactones (STL) supplemented diet. Relative abundances detected by NGS are expressed as means. Phyla with abundance under 0.1% are grouped in “Others”. (B) Standardized abundance ratio relative to D0 of Firmicutes and Bacteroidetes (Tukey’s test, n = 5/group, * for p < 0.1). Chic—chicory flour; Fru–fructose; CGA—chlorogenic acids; STL—sesquiterpene lactones; Ctr1—control related to Chic and Fru diet; Ctr2—control related to CGA and STL diet.
Figure 4. Changes in bacterial phyla abundance. (A) Relative abundance (%) of phyla in mice microbiota before (D0) and after 30 days (D30) of chicory (Chic), fructose (Fru), chlorogenic acids (CGA) or sesquiterpene lactones (STL) supplemented diet. Relative abundances detected by NGS are expressed as means. Phyla with abundance under 0.1% are grouped in “Others”. (B) Standardized abundance ratio relative to D0 of Firmicutes and Bacteroidetes (Tukey’s test, n = 5/group, * for p < 0.1). Chic—chicory flour; Fru–fructose; CGA—chlorogenic acids; STL—sesquiterpene lactones; Ctr1—control related to Chic and Fru diet; Ctr2—control related to CGA and STL diet.
Nutrients 14 00957 g004
Figure 5. Relative abundance of main genera in mice fecal microbiota after chicory flour (Chic), fructose (Fru), chlorogenic acids (CGA) or sesquiterpene lactones (STL) diet. (A) Relative abundances of genera (%) are indicated when their values are >0.1%. Genera with a low relative abundance were assigned as “Others”. (B) Heatmap representing the fold change of standardized abundance ratio. Increased abundance compared to control was considered when FC > 1.30 (red squares) and decreased when <0.70 (green squares).
Figure 5. Relative abundance of main genera in mice fecal microbiota after chicory flour (Chic), fructose (Fru), chlorogenic acids (CGA) or sesquiterpene lactones (STL) diet. (A) Relative abundances of genera (%) are indicated when their values are >0.1%. Genera with a low relative abundance were assigned as “Others”. (B) Heatmap representing the fold change of standardized abundance ratio. Increased abundance compared to control was considered when FC > 1.30 (red squares) and decreased when <0.70 (green squares).
Nutrients 14 00957 g005
Figure 6. Dot plots illustrating the apoptotic effect of chicory flour and its compounds on HepG2 cells. HepG2 cells were treated for 24 h with chicory decoction (Chic), fructose (Fru), CGA and STL solutions at different concentrations and analyzed using propidium iodide and Annexin V. Representations were selected among the most elevated concentration of each compound (3% for Chic and Fru; 100 µM for CGA and STL). Resveratrol at a concentration of 200 µM was used as a positive control, and DMEM as a negative one. The top left quadrant of each plot represents unviable cells, the top right quadrant represents necrotic cells or cells in late apoptosis. The bottom left quadrant represents viable cells and the bottom right quadrant represents early apoptotic cells. Total apoptotic cells were calculated by adding the top right and bottom right quadrant’s content. Samples illustrated in the top of the figure (Resveratrol, Chic and STL) provided an increased apoptotic effect compared to the other samples.
Figure 6. Dot plots illustrating the apoptotic effect of chicory flour and its compounds on HepG2 cells. HepG2 cells were treated for 24 h with chicory decoction (Chic), fructose (Fru), CGA and STL solutions at different concentrations and analyzed using propidium iodide and Annexin V. Representations were selected among the most elevated concentration of each compound (3% for Chic and Fru; 100 µM for CGA and STL). Resveratrol at a concentration of 200 µM was used as a positive control, and DMEM as a negative one. The top left quadrant of each plot represents unviable cells, the top right quadrant represents necrotic cells or cells in late apoptosis. The bottom left quadrant represents viable cells and the bottom right quadrant represents early apoptotic cells. Total apoptotic cells were calculated by adding the top right and bottom right quadrant’s content. Samples illustrated in the top of the figure (Resveratrol, Chic and STL) provided an increased apoptotic effect compared to the other samples.
Nutrients 14 00957 g006
Figure 7. Apoptosis induction on HepG2 cells. HepG2 cells were treated with various concentrations of a chicory flour decoction (Chic) or D-fructose solution (Fru) (from 0.2% to 3%), and also with chlorogenic acids (CGA) or sesquiterpene lactones (STL) (from 5 µM to 100 µM) for 24 h. Resveratrol at a concentration of 200 µM was used as a positive control and DMEM and DMSO as negative ones. As no significant variations were registered between negative controls, the apoptosis induction in each condition was compared to the DMEM control and expressed as a ratio. Statistical analysis was performed using one-way ANOVA and Dunnett’s multiple comparisons test (**** p < 0.0001; *** p < 0.0005 compared with the DMEM control).
Figure 7. Apoptosis induction on HepG2 cells. HepG2 cells were treated with various concentrations of a chicory flour decoction (Chic) or D-fructose solution (Fru) (from 0.2% to 3%), and also with chlorogenic acids (CGA) or sesquiterpene lactones (STL) (from 5 µM to 100 µM) for 24 h. Resveratrol at a concentration of 200 µM was used as a positive control and DMEM and DMSO as negative ones. As no significant variations were registered between negative controls, the apoptosis induction in each condition was compared to the DMEM control and expressed as a ratio. Statistical analysis was performed using one-way ANOVA and Dunnett’s multiple comparisons test (**** p < 0.0001; *** p < 0.0005 compared with the DMEM control).
Nutrients 14 00957 g007
Figure 8. Effects of chicory and its compounds on TNF-α, IL-1β and IL-8 production by human U937 macrophages. U937 were differentiated with PMA before being inflamed with LPS (w/LPS) and put in contact with samples for 2 h. Dexamethasone (dexa) was used as a negative control of inflammation. Efficiency of LPS inflammation was controlled (RPMI w/o LPS) in each test. Cytokine levels were expressed as a ratio of the control (RPMI w/LPS) level. Statistical analysis was performed using one-way ANOVA and Dunnett’s multiple comparisons test (* p < 0.05; ** p < 0.005; **** p < 0.0001 against control). dexa: 20 µM of dexamethasone; chic: 1% of chicory flour decoction; Fru: 1% of D-fructose; CGA: 20 µM of chlorogenic acids mix; STL: 20 µM of sesquiterpene lactone mix.
Figure 8. Effects of chicory and its compounds on TNF-α, IL-1β and IL-8 production by human U937 macrophages. U937 were differentiated with PMA before being inflamed with LPS (w/LPS) and put in contact with samples for 2 h. Dexamethasone (dexa) was used as a negative control of inflammation. Efficiency of LPS inflammation was controlled (RPMI w/o LPS) in each test. Cytokine levels were expressed as a ratio of the control (RPMI w/LPS) level. Statistical analysis was performed using one-way ANOVA and Dunnett’s multiple comparisons test (* p < 0.05; ** p < 0.005; **** p < 0.0001 against control). dexa: 20 µM of dexamethasone; chic: 1% of chicory flour decoction; Fru: 1% of D-fructose; CGA: 20 µM of chlorogenic acids mix; STL: 20 µM of sesquiterpene lactone mix.
Nutrients 14 00957 g008
Figure 9. Antioxidative effects of chicory flour. Superoxide anion inhibition (A) and hydroxyl radical inhibition (B) of chicory flour decoction were observed by contrast with the effect of the negative control (T ED) containing distilled water, and the positive control containing cysteine (T cys). The sample decoction of chicory flour (Chic) was tested at increasing concentrations, ranging from 0.25 to 1 mg of dry matter equivalent per final mL. Statistical analysis for n = 6 independent assays were performed with ANOVA: overall Fisher’s test, p < 0.0001; Tukey’s test, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (A) and Kruskal-Wallis test, p = 0.0017; Dunn’s test, ** p < 0.01 (B).
Figure 9. Antioxidative effects of chicory flour. Superoxide anion inhibition (A) and hydroxyl radical inhibition (B) of chicory flour decoction were observed by contrast with the effect of the negative control (T ED) containing distilled water, and the positive control containing cysteine (T cys). The sample decoction of chicory flour (Chic) was tested at increasing concentrations, ranging from 0.25 to 1 mg of dry matter equivalent per final mL. Statistical analysis for n = 6 independent assays were performed with ANOVA: overall Fisher’s test, p < 0.0001; Tukey’s test, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (A) and Kruskal-Wallis test, p = 0.0017; Dunn’s test, ** p < 0.01 (B).
Nutrients 14 00957 g009
Figure 10. Venn diagram illustrating an estimation of the most important effects of the chicory and its tested compounds: fructose (Fru), chlorogenic acids (CGA) and sesquiterpene lactones (STL). Number of DEGs was considered in transcriptome analysis, and number of modified taxa in metagenetic analysis. Results of hormone assay were constricted to significant modification as well as for in vitro analyses as significant response was considered 1 and a non-significant one was considered 0. A score was calculated by totaling these events for each diet. The Venn diagram’s platform (http://bioinfogp.cnb.csic.es/tools/venny/index.html accessed on 21 January 2022) was used to cross the data.
Figure 10. Venn diagram illustrating an estimation of the most important effects of the chicory and its tested compounds: fructose (Fru), chlorogenic acids (CGA) and sesquiterpene lactones (STL). Number of DEGs was considered in transcriptome analysis, and number of modified taxa in metagenetic analysis. Results of hormone assay were constricted to significant modification as well as for in vitro analyses as significant response was considered 1 and a non-significant one was considered 0. A score was calculated by totaling these events for each diet. The Venn diagram’s platform (http://bioinfogp.cnb.csic.es/tools/venny/index.html accessed on 21 January 2022) was used to cross the data.
Nutrients 14 00957 g010
Table 1. Composition of Fru, CGA and STL solutions used for feeding mice.
Table 1. Composition of Fru, CGA and STL solutions used for feeding mice.
TreatmentFruCGASTL
CompoundFructose3-CGA3,5-CGADHLcLcDHLpLp
µg/day of each compound166.352.523.441.833.880.292.22
µg/day of total mix166.355.908.20
3-CGA: 3-mono-O-caffeoylquinic acid; 3,5-CGA: 3,5-di-O-caffeoylquinic acid; DHLc: 11β,13-Dihydrolactucin; Lc: Lactucin; DHLp: 11β,13-Dihydrolactucopicrin; Lp: Lactucopicrin. The administered doses are based on results obtained for the content of chicory roots and reported to 30 mg/day of chicory flour.
Table 2. Major metabolites analysed by quantitative 1H-NMR and UPLC/ESI-HRMS in chicory root flour and decoction.
Table 2. Major metabolites analysed by quantitative 1H-NMR and UPLC/ESI-HRMS in chicory root flour and decoction.
Compounds
(mg/g Dry Matter)
FlourDecoction
MeanSDMeanSD
Fructose a3.430.122.600.26
3-CGA b0.550.020.660.01
3,5-diCGA b0.430.010.430.01
Lc c0.050.010.110.01
Lp c0.230.020.210.01
DHLc c0.140.010.170.01
DHLp c0.050.010.030.01
a quantitative 1H-NMR, bin (3.54) corresponding to 1H linked to C1, b UPLC/ESI-HRMS in negative ionization mode and c in positive ionization mode. 3-CGA: 3-mono-O-caffeoylquinic acid, m/z 353.0878 at RT 1.08 min; 3,5-diCGA: 3,5-di-O-caffeoylquinic acid, m/z 515.1195 at RT 4.27 min; Lc: Lactucin, m/z 299.0889 at RT 3.02 min; Lp: Lactucopicrin, m/z 433.1257 at RT 5.77 min; DHLc: 11β,13-Dihydrolactucin, m/z 279.1227 at RT 2.59 min; DHLp: 11β,13-Dihydrolactucopicrin, m/z 435.1414 at RT 5.72 min.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Pouille, C.L.; Ouaza, S.; Roels, E.; Behra, J.; Tourret, M.; Molinié, R.; Fontaine, J.-X.; Mathiron, D.; Gagneul, D.; Taminiau, B.; et al. Chicory: Understanding the Effects and Effectors of This Functional Food. Nutrients 2022, 14, 957. https://doi.org/10.3390/nu14050957

AMA Style

Pouille CL, Ouaza S, Roels E, Behra J, Tourret M, Molinié R, Fontaine J-X, Mathiron D, Gagneul D, Taminiau B, et al. Chicory: Understanding the Effects and Effectors of This Functional Food. Nutrients. 2022; 14(5):957. https://doi.org/10.3390/nu14050957

Chicago/Turabian Style

Pouille, Céline L., Souad Ouaza, Elise Roels, Josette Behra, Melissa Tourret, Roland Molinié, Jean-Xavier Fontaine, David Mathiron, David Gagneul, Bernard Taminiau, and et al. 2022. "Chicory: Understanding the Effects and Effectors of This Functional Food" Nutrients 14, no. 5: 957. https://doi.org/10.3390/nu14050957

APA Style

Pouille, C. L., Ouaza, S., Roels, E., Behra, J., Tourret, M., Molinié, R., Fontaine, J. -X., Mathiron, D., Gagneul, D., Taminiau, B., Daube, G., Ravallec, R., Rambaud, C., Hilbert, J. -L., Cudennec, B., & Lucau-Danila, A. (2022). Chicory: Understanding the Effects and Effectors of This Functional Food. Nutrients, 14(5), 957. https://doi.org/10.3390/nu14050957

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop